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ABSTRACT 
Yan Li 
INHIBITORY SYNAPTIC TRANSMISSION IN STRIATAL NEURONS 
AFTER TRANSIENT CEREBRAL ISCHEMIA 
In the striatum, large aspiny (LA) interneurons survive transient cerebral ischemia 
while medium spiny (MS) neurons die.  Excitotoxicity is believed to be the major 
cause for neuronal death after ischemia.  Since inhibitory tone plays an important 
role in the control of neuronal excitability, the present study is aimed at 
examining if there are any changes in inhibitory synaptic transmission in striatal 
neurons after ischemia and the possible mechanisms.   
Transient forebrain ischemia was induced in male Wistar rats using the 
four-vessel occlusion method.  Inhibitory postsynaptic currents (IPSCs) were 
evoked intrastriatally and whole-cell voltage-clamp recording was performed on 
striatal slices.  The expression of glutamate decarboxylase65 (GAD65) was 
analyzed using immunohistochemical studies and Western blotting.  Muscimol (a 
specific GABAA receptor agonist) was injected intraperitoneally to the rats (1 
mg/kg) to observe ischemic damage, evaluated by counting the survived cells in 
the striatum after hematoxylin & eosin (HE) staining.  
The amplitudes of evoked IPSCs were significantly increased in LA 
neurons while depressed in MS neurons after ischemia.  This enhancement was 
due to the increase of presynaptic release.  Muscimol (1 μM) presynaptically 
facilitated inhibitory synaptic transmission in LA neurons at 24 h after ischemia.  
The optical density of GAD65-positive terminals and the number of GAD65-
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positive puncta was significantly increased in the striatum at both 1 day and 3 
days after ischemia.  Consistently, data from western blotting suggested an 
increased expression of GAD65 in the striatum after ischemia.  For the rats 
treated with muscimol, the number of survived cells in the striatum was greatly 
increased compared to the non-treatment group.   
The present study demonstrates an enhancement of inhibitory synaptic 
transmission in LA neurons after ischemia, which is contributed by two 
mechanisms.  One is the increased presynaptic release of GABA mediated by 
presynaptic GABAA receptors.  The other is the increased expression of GAD.  
Facilitation of inhibitory synaptic transmission by muscimol protects striatal 
neurons against ischemia.  Therefore, the enhancement of inhibitory synaptic 
transmission might reduce excitotoxicity and contribute to the selective survival of 
LA neurons after ischemia.   
 
Zao C. Xu, M.D., Ph.D., Chair 
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INTRODUCTION 
Stroke 
Stroke occurs when a blood clot blocks an artery (ischemic stroke, 80%) or a 
blood vessel breaks (hemorrhagic stroke, 20%), interrupting blood flow to an 
area of the brain (definition from National Stroke Association).  Ischemic stroke is 
classified into focal ischemia and global ischemia.  Global ischemia is normally 
seen in patients after heart attack.  
As the third leading cause of death and the number one cause of adult 
disability in the western world, stroke draws lots of devotion from neuroscientists 
and pharmaceutical companies.  Disappointingly, the only approved drug therapy 
for stroke is tissue plasminogen activator, which acts to restore cerebral blood 
flow.  For the last two decades, neuroprotection agents were the hope for stroke 
treatment.  However, most of the neuroprotection agents including the ones for 
glutamate antagonism and GABA agonism, failed in clinical trials.  The following 
key factors are blamed for the failure of the translational study.  The first is that 
the time-window to treatment in animal study does not match the one in clinical 
trials.  The second is that animal models do not mimic human stroke due to the 
difference in age, anatomy and other complications.  The third is that the plasma 
concentration of the agent in clinical trials cannot reach the one in animal studies.  
All these leave us a big space to reconsider the design of the animal studies and 
clinical trials (Ginsberg, 2008).  Besides the new neuroprotection therapy 
considered, Lipton (Lipton, 2007) suggested that neuroprotection agents, which 
are activated by the pathological state that they are intended to inhibit, should be 
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developed.  Other approach, like the stimulation of brain’s endogenous repair 
mechanisms, might bring new hope for the stroke therapy (Garber, 2007).    
Excitotoxicity and postischemic neuronal injury 
Onley (Olney et al., 1972) first coined the term excitotoxicity as too much 
glutamate release can be destructive and excite a neuron to death.  Excitotoxicity 
has been widely accepted as one of the major causes for postischemic cell death.  
During cerebral ischemia, Na+-K+-ATPase on the membrane loses its function to 
transfer Na+ out of the cell and K+ into the cell, which results in membrane 
depolarization and the rundown of ionic gradients (Hansen, 1985; Lipton, 1999).  
A dramatic increase in extracellular glutamate concentration is found during 
cerebral ischemia by utilizing microdialysis (Benveniste et al., 1984; Globus et al., 
1988; Globus et al., 1991).  Excessive glutamate release is initially caused by 
Ca2+-dependent exocytosis and later by the reversal uptake of glutamate 
transporters (Katchman and Hershkowitz, 1993; Madl and Burgesser, 1993; 
Roettger and Lipton, 1996; Rossi et al., 2000).   
Through its interaction with ionotropic NMDA (N-methyl-D-aspartate) and 
AMPA (alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid) receptors, 
glutamate triggers excessive calcium and sodium influx into the neurons (Andine 
et al., 1988; Benveniste et al., 1988).  Voltage-gated calcium channels also 
contribute to an increase of intracellular calcium during ischemia (Paschen, 2000; 
Zipfel et al., 1999).  Intracellular calcium overload activates an array of 
downstream phospholipases and proteases that will degrade membranes and 
proteins important for cellular integrity (Choi and Rothman, 1990; Rothman and 
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Olney, 1986).  Additionally, intracellular calcium overload will sequestrate calcium 
into mitochondria (Dux et al., 1987; Sims and Pulsinelli, 1987) and induce 
mitochondrial damage through two ways.  One is by the activation of enzymes to 
generate reactive oxygen species (ROS); the other is the formation of 
mitochondrial pore, which facilitates the release of apoptosis-related proteins 
(Starkov et al., 2004).  The final consequence is oxidative stress, apoptosis 
and/or necrosis.  Therefore, calcium overload is the central theme for 
excitotoxicity and the final path leading to neuronal death (Figure 1). 
In animal studies, application of antagonists to ionotropic glutamate 
receptors protect cells from ischemic injury (Boast et al., 1988; Buchan et al., 
1991; Marcoux et al., 1988; Nellgard and Wieloch, 1992; Noh et al., 2005; Simon 
et al., 1984).  However, failure of NMDA and AMPA receptor antagonists in 
clinical trials (Albers et al., 1995; Albers et al., 2001; Davis et al., 1997; Diener et 
al., 2002; Dyker and Lees, 1999; Elting et al., 2002) suggests that other 
mechanisms might be involved.  Some efforts have been focused on glutamate 
receptor-independent Ca2+-permeable ion channels.  Antagonists to voltage-
gated calcium channels have been shown neuroprotective after cerebral 
ischemia in animal studies (Germano et al., 1987; Hara et al., 1990) but cannot 
be confirmed in clinical trials (Horn and Limburg, 2001).  TRPM7 is a member of 
the transient receptor potential melastatin (TRPM) subfamily.  Aarts et al. (Aarts 
et al., 2003) showed that blockade of TRPM7 currents attenuated anoxic 
neuronal death by reducing anoxic Ca2+ uptake and ROS production.  Acid-
sensing ion channels (ASICs) are activated by acidosis.  Blocking ASICs protects 
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neurons from ischemic insults in vivo and in vitro (Xiong et al., 2004).  Ca2+ 
extruding system on the plasma membrane, like Na+/Ca2+ exchanger (NCX), has 
also been shown to play a role in cerebral ischemia (Bano et al., 2005; Pignataro 
et al., 2004a; Pignataro et al., 2004b).  Besides Ca2+, ionic imbalances caused by 
other ions, like Zn2+ (Sensi and Jeng, 2004) and K+ (Yu et al., 2001), has been 
extensively studied in cerebral ischemia. 
Remarks:  
Excitotoxicity is believed to be the main mechanism for postischemic neuronal 
death.  Calcium overload is the central theme for excitotoxicity and the final path 
leading to neuronal death. 
Striatum: the microcircuits and function 
In the basal ganglia, most of the inputs go to two nuclei, the striatum and the 
subthalamic nucleus.  And most of the outputs are through two nuclei, the 
internal segment of globus pallidus (GP) and the substantia nigra pars reticulata.  
Besides these input and output nuclei, there are relay nuclei, the external 
segment of GP, the substantia nigra pars compacta and the ventral tegmental 
area, providing and receiving inputs from other nuclei in the basal ganglia 
(Alexander and Crutcher, 1990).  As the largest nuclei in the basal ganglia, 
striatum is actively involved in the sensory-motor functions, as well as in the 
cognitive and limbic functions.  Striatum has several sources of inputs.  It 
receives excitatory inputs from cerebral cortex, thalamus, and limbic structures 
like hippocampus and amygdala.  It also receives dopaminergic afferents from 
substantia nigra pars compacta and serotonergic afferents from dorsal raphe 
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nucleus in the midbrain (Tepper et al., 2007).  Studies from Bevan showed that 
there are GABAergic inputs from GP to the striatum (Bevan, 1998) (Figure 2).  
The projection neurons in the striatum are GABAergic medium spiny (MS) 
neurons, which accounts for about 97.7% of the neuronal populations in the 
rodents (Rymar et al., 2004).  There are two main populations of MS neurons.  
One population of MS neurons, with highly collateralized axons, expresses 
Substance P, Dynorphin and mainly D1-type dopamine receptors.  They project 
to the internal segment of GP and substantial nigra, which is called direct 
pathway.  The other population of MS neurons expresses Enkephalin and mainly 
D2-type dopamine receptors.  They project to the external segment of GP and 
subthalamic nucleus, which is called indirect pathway.  The information flowed 
through the direct and indirect pathway finally goes back to the thalamus and 
cerebral cortex, where the striatum originally receive the inputs from (Gerfen, 
1992; Graybiel, 1990)  (Figure 2).   
MS neurons receive the excitatory afferents from both the cortex and 
thalamus.  And these afferents mainly innervate the spines of MS neurons 
(Frotscher et al., 1981; Somogyi et al., 1981).  MS neurons receive GABAergic 
inputs from GABAergic interneurons in the striatum (Koos and Tepper, 1999) and 
axon collaterals of other MS neurons (Guzman et al., 2003; Tunstall et al., 2002) 
(Figure 3).  Although the axonal collaterals of MS neurons are dense and 
widespread in the striatum (Oorschot, 1996), in vivo and in vitro studies 
demonstrated that collateral inhibitions between MS neurons are weak (Jaeger et 
al., 1994; Stern et al., 1998; Tunstall et al., 2002).  On the contrary, as the minor 
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neuronal populations in the striatum (2%) (Rymar et al., 2004), GABAergic 
interneurons provide strong inhibitory inputs to MS neurons as demonstrated by 
large amplitude of inhibitory postsynaptic potentials and low failure rate (Koos 
and Tepper, 1999; Koos et al., 2004).  The GABAergic interneurons, thus, are 
believed to provide the feedforward inhibition, while the recurrent axon collaterals 
of MS neurons provide the feedback inhibition in the striatum (Tepper et al., 
2004).  
Besides MS neurons, other neurons in the striatum are interneurons, 
which can be categorized into two types, cholinergic large aspiny  neurons and 
GABAergic interneurons based on the neurotransmitter they produce.  Therefore, 
LA neurons are believed to be the only non-GABAergic neurons in the striatum 
(Wilson, 2007).  Different from MS neurons, LA neurons receive substantial 
excitatory inputs from the thalamus but are almost devoid of corticostriatal 
afferents, except for light innervations of distal dendrites (Lapper and Bolam, 
1992; Meredith and Wouterlood, 1990).  LA neurons receive GABAergic inputs 
from the axon collaterals of MS neurons (Bolam et al., 1986; Martone et al., 1992) 
(Figure 3).    
LA neurons provide strong cholinergic innervations to striatal neurons 
since acetylcholine (ACh) is tonically released and their axonal arborizations are 
dense and large.  The release of ACh is modulated not only by synaptic inputs 
but also by neuromodulators and autoreceptors on the cholinergic terminals.  For 
example, activation of D2 dopamine receptors reduces autonomous spiking in LA 
neurons (DeBoer et al., 1996).  Activation of M4 Muscarinic receptors (mACh) 
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located on the cholinergic terminals reduces ACh release (Calabresi et al., 1998b; 
Ding et al., 2006).  
Muscarinic and nicotinic ACh (nACh) receptors are widely distributed in 
the striatum.  They are either expressed on the presynaptic terminals, modulating 
presynaptic transmitter release, or on the postsynaptic sites, causing excitation 
or inhibition.  For example, dopaminergic afferents to the striatum express M4 
receptors and nACh receptors.  The activation of M4 receptors will decrease 
dopamine release while the activation of nACh receptors will increase dopamine 
release (Rice and Cragg, 2004).  Glutamatergic afferents to the striatum express 
M2 and M3 receptors (Hersch et al., 1994), the activation of which will inhibit 
glutamate release as demonstrated in the paired recordings (Pakhotin and Bracci, 
2007).  Fast spiking (FS) interneurons, a kind of GABAergic interneurons in the 
striatum, express nACh receptors.  The activation of nACh receptors produces 
powerful excitation in FS interneurons (Koos and Tepper, 2002).  Therefore, LA 
neurons directly or indirectly participate in the modulation of feedforward and 
feedback inhibition.       
It has long been known that LA neurons are actively involved in motivation 
and reward learning (Graybiel et al., 1994).  They respond to salient stimuli 
during associative learning by displaying a pause, preceded or followed by 
increased spikes (Aosaki et al., 1994; Apicella, 2002).  The understanding of LA 
neurons’ function in movement control largely benefits from the research in 
movement disorders.  In Parkinson’s disease (PD), the dopaminergic afferents to 
the striatum is depleted while the cholinergic signaling is enhanced.  In 
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Huntington’s disease, research from Smith et al. suggests that there might be a 
dysfunctional cholinergic signaling (Smith et al., 2006).  LA neurons’ function in 
the striatum is still under active investigation.  In fact, we could get some hint 
from the functional study of cholinergic neurons in the basal forebrain, in which 
saporin is used to selectively immunolesion the cholinergic neurons.  Saporin is 
coupled to a monoclonal antibody against a certain receptor, which is exclusively 
expressed by cholinergic neurons in the basal forebrain (Wenk et al., 1994). 
Remarks: 
The striatum is involved in sensory-motor functions.  MS neurons form direct and 
indirect pathways, which convey the information from the cortex and thalamus, 
process it and send it back to where it is from.  LA neurons, which are the only 
non-GABAergic neurons in the striatum, actively participate in reward learning 
and movement control.     
Electrophysiological and immunohistochemical characters of striatal 
neurons 
In vivo recording revealed that the most characteristic electrophysiological 
property of MS neurons is their two-state membrane potential.  That is, their 
membrane potential is maintained either at a depolarized UP state, where the 
action potentials are elicited from, or a hyperpolarized DOWN state.  The UP 
state is caused by strong and sustained excitatory inputs from the cerebral cortex 
and thalamus.  The DOWN state is dominated by the inwardly rectifying 
potassium conductances (Wilson and Kawaguchi, 1996).  For years, it is believed 
that the morphological and electrophysiological properties are homogenous 
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among MS neurons although they are functionally heterogeneous; with some of 
the MS neurons forming the direct pathway while the others forming the indirect 
pathway.  The development of the transgenic mice, in which different groups of 
MS neurons could be identified, helps to prove that these two groups of MS 
neurons are in fact electrophysiologically and morphologically dichotomous (Day 
et al., 2008; Gertler et al., 2008).  There are several immunohistochemical 
markers for MS neurons.  They express calbindin and dopamine- and cAMP-
dependent phosphoprotein of 32 kDa (DARPP-32).  For the MS neurons forming 
the direct pathway, they express Substance P, Dynorphin, and D1 receptors.  For 
the MS neurons forming the indirect pathway, they express Enkephalin and D2 
receptors.  Different from the striatal GABAergic interneurons, which express 
predominantly glutamate decarboxylase 67 (GAD67), they mainly express 
GAD65, the key enzyme in the synthesis of GABA. 
LA neurons represent 0.3% of the neuronal population in the striatum 
(Rymar et al., 2004).  They have an elongated cell body around 50 µm with the 
shortest diameter around 20 μm.  They are tonically active neurons, firing action 
potentials as the consequence of the interplay among intrinsic membrane 
conductances even without synaptic inputs.  With broad action potentials, more 
calcium gets in LA neurons through voltage-gated calcium channels and at the 
same time activating the calcium-activated potassium channels.  As the 
membrane goes to the hyperpolarizing direction, the calcium-activated potassium 
channels are inactivated and the hyperpolarization and cyclic adenosine 
monophosphate dependent cation (HCN) channels are activated.  The activation 
10 
 
of HCN channels results in membrane depolarization and if the depolarization 
reaches the threshold to activate voltage-gated sodium channels, an action 
potential occurs (Bennett and Wilson, 1999; Wilson, 2005).  HCN channels are 
also responsible for the large-amplitude and long-duration afterhyperpolarizations 
following the action potentials in LA neurons.  If negative currents are injected, an 
initial hyperpolarization could be observed, followed by sag, which is also caused 
by the activation of HCN channels (Jiang and North, 1991; Kawaguchi, 1993).  
LA neurons are strongly stained for the cholinergic markers, choline 
acetyltransferase (CHAT), acetylcholinesterase, and vesicular Ach transporter.     
GABAergic interneurons comprise totally about 2% in the striatal 
population (Rymar et al., 2004).  They could be categorized as three types based 
on both electrophysiological and neurochemical characters (Kawaguchi et al., 
1995).  One group of GABAergic interneurons are parvalbumin (PV)-positive.  
They are also called fast-spiking GABAergic interneurons since they fire short 
duration action potentials at very high frequency (200-300 Hz) without little 
frequency adaptation. They also show deep afterhyperpolarizations (Kawaguchi, 
1993).  Gap junctions exist among these neurons and they provide strong 
inhibitory inputs to MS neurons (Koos et al., 2004).  The second group of 
GABAergic interneurons contains neuropeptide Y (NPY), somatostatin (SOM), 
nitric oxide synthase (NOS) and NADPH diaphorase.  Electrophysiologically, they 
show low threshold calcium spikes and are thus named low-threshold spike (LTS) 
neurons (Kawaguchi, 1993).  They also provide strong inhibitory inputs to MS 
neurons (Tepper and Bolam, 2004).  The other group of GABAergic interneurons 
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contains calretinin and their electrophysiological properties are still unknown.  
GAD67 is strongly expressed in the GABAergic interneurons, the other isoform of 
GAD, with the exception of SOM-containing GABAergic interneurons.  Normally, 
GAD67 could not be detected in SOM-containing GABAergic interneurons 
although GABA immunoreactivity could be detected in their terminals (Kawaguchi 
et al., 1995).    
There are also a very small group of dopaminergic neurons in the striatum.  
They express tyrosin hydroxylase (TH) and dopamine transporter (DAT).  They 
also express GAD67, a marker for GABAergic neurons (Huot and Parent, 2007).  
The electrophysiological properties of these neurons are still under investigation. 
Remarks: 
Striatal neurons could be identified by their electrophysiological and 
neurochemical characters (for summary, see table 1).  Most of the striatal 
neurons are GABAergic and LA neurons are the only non-GABAergic neurons in 
the striatum. 
Selective cell death in the striatum after ischemia 
Transient global ischemia, as a result of cardiac arrest in humans, induces 
selective neuronal death in vulnerable brain regions.  In the hippocampus, CA1 
neurons die while CA3 neurons survive (Kirino, 1982; Pulsinelli et al., 1982).  In 
the striatum, MS neurons in the dorsolateral part show visible damage as early 
as 6 h after transient cerebral ischemia and most of them die in 24 h (Pulsinelli et 
al., 1982).  Most of the interneurons including LA neurons, calretinin-containing 
and SOM-containing neurons survive ischemia (Chesselet et al., 1990).  Whether 
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PV-positive neurons survive ischemia or not remains controversial.  In the global 
ischemia model of gerbil (Gonzales et al., 1992) and focal ischemia model in 
mouse (Katchanov et al., 2003), they are spared from ischemic insults.  By 
contrast, studies from Larsson et al. (Larsson et al., 2001; Meade et al., 2000) 
showed that PV-positive interneurons were dramatically lost after global ischemia 
in rats.   
The mechanisms for such selective neuronal death in the striatum are 
under intensive investigation.  It is found that the intrinsic membrane properties 
change differentially in MS and LA neurons after ischemia.  MS neurons undergo 
depolarization due to the activation of TTX-insensitive sodium channels while LA 
neurons undergo hyperpolarization due to the activation of ATP- and Ca2+-
dependent potassium channels (Calabresi et al., 1997; Centonze et al., 2001a; 
Pisani et al., 1999).  Studies from Deng et al. demonstrated that LA neurons 
have decreased excitability after ischemia.  Delayed rectifier potassium currents 
are enhanced while Ih currents through HCN channels are inhibited in LA 
neurons after ischemia (Deng et al., 2005; Deng et al., 2008).  These two types 
of neurons also respond differentially to excitatory inputs after ischemia.  For the 
activation of ionotropic glutamate receptors, larger depolarizations occur in MS 
neurons than in LA neurons upon the application of glutamate receptor agonist 
(Calabresi et al., 1998a).  For the activation of metabotropic glutamate receptors, 
membrane depolarization and calcium accumulation occur in MS neurons but not 
in LA neurons (Calabresi et al., 1999).  Ischemic-long term potentiation (LTP) 
occurs in MS neurons but not in LA neurons (Calabresi et al., 2002).  Studies 
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from this lab have shown that excitatory synaptic transmission change 
differentially in these two types of neurons after ischemia.  LA neurons have 
decreased excitatory synaptic transmission (Pang et al., 2002) while MS neurons 
show increased excitatory synaptic transmission (Zhang et al., 2006).   
The massive degeneration of MS neurons (especially the ones in the 
dorsolateral striatum) and the relative sparing of striatal interneurons after 
ischemia resemble that in Huntington’s disease (Meade et al., 2000).  However, 
is it reasonable to speculate that rats after ischemia will show the movement 
disorder as seen in the patients with Huntington’s disease?  Previous studies 
developed a motor score to test neurological deficits in equilibrium and muscle 
strength.  Ischemic rats show neurological deficits in 24 h but transient cerebral 
ischemia does not result in long lasting neurological deficits (Combs and D'Alecy, 
1987; Gionet et al., 1991).  The deficits in spatial learning and swim speed seen 
in the ischemic rats are also correlated with striatal damage (Block and Schwarz, 
1998; Whishaw et al., 1987).  Since neuronal death also happens in the 
hippocampus, especially in the CA1 area, deficits in learning and memory are 
very obvious in the rats after transient cerebral ischemia (Block, 1999).  However, 
ischemia-induced functional deficits could be better understood if selective 
excitotoxic damages would be produced selectively in a certain brain area, either 
in the striatum or in the hippocampus. 
Remarks:   
LA neurons survive while MS neurons (especially the ones in the dorsolateral 
striatum) die after transient cerebral ischemia.  The mechanism of this selective 
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cell death after ischemia and its functional meaning is still under investigation.  
Previous studies showed that these two types of neurons show differential 
changes in intrinsic membrane properties and excitatory synaptic transmission 
after ischemia.  However, the role of inhibitory synaptic transmission in this 
selective vulnerability is still unknown. 
Inhibitory synaptic transmission and postischemic neuronal injury 
GABA is the major inhibitory neurotransmitter in the central nervous system.  
There are three types of GABA receptors, GABAA, GABAB and GABAC (Chebib 
and Johnston, 1999).  For mature neurons, activation of postsynaptic GABAA 
receptors causes Cl- influx that mediates fast synaptic inhibition, which is called 
phasic inhibition (Cherubini and Conti, 2001; Gaiarsa et al., 2002; Mody et al., 
1994).  Spillover of GABA and the activation of extrasynaptic GABAA receptors 
cause tonic inhibition (Nusser et al., 1998; Semyanov et al., 2004; Wei et al., 
2003).  Activation of GABAB receptors triggers G-protein coupled events and 
mediates a slow inhibitory response via potassium channels (Mott and Lewis, 
1994).  GABAC is also a chloride channel mainly expressed in vertebrate retina 
(Johnston, 1996).  Therefore, activation of GABA receptors results in membrane 
hyperpolarization.   
GABAA and GABAC receptors are both transmitter-gated ion channels.   
They are composed of five subunits and each subunit has four transmembrane 
domains.  The second transmembrane domain forms the wall of the channel 
pore.  There are 16 subunits (α1–6, β1–4, γ1–4, δ, ε) encoded for GABAA 
receptors.  The diversity of the subunits and the existence of different isoforms 
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for the different subunits yield a huge amount of combinations.  But a fully 
functional GABAA receptor requires one α, β, and one other subunit type, such as 
γ, δ or ε (Chebib and Johnston, 1999).  GABAC receptors are homo-
oligomerically formed by ρ1 and ρ2 subunits (Johnston, 1996).  GABAB receptors 
are seven transmembrane metabotropic receptors encoded by two genes-
GABABR1 and GABABR2.  Heterodimerization between GABABR1 and R2 
subunits is required for the formation of fully functional GABAB receptors (Bettler 
et al., 2004; Couve et al., 2004).   
Excitotoxicity is believed to be the major mechanism for postischemic 
neuronal death.  The membrane depolarization caused by the energy failure is 
the initiating step to the cascades of excessive glutamate release, over activation 
of postsynaptic glutamate receptors, calcium overload, and cell death.  Since 
GABAergic synaptic transmission is an important tone in the control of neuronal 
excitability and GABA functions in opposite to glutamate, GABAergic synaptic 
transmission might be neuroprotective after ischemia.  In fact, ample evidence 
from animal studies has demonstrated that GABAmimetic drugs are 
neuroprotective after ischemia.  For example, muscimol, a specific GABAA 
receptor agonist, is proved to decrease the infarct size and improve the 
functional recovery after focal ischemia (Lyden and Hedges, 1992; Lyden et al., 
2000; Lyden and Lonzo, 1994).  Muscimol improves the survival of hippocampal 
CA1 neurons after global ischemia (Han et al., 2008; Xiao et al., 2007; Xu et al., 
2008; Zhang et al., 2007; Zhou et al., 2008).  With in vitro ischemia, muscimol 
helps recover the field potential in the striatum (Costa et al., 2004) and 
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decreases the apoptosis of CA1 neurons (Han et al., 2008).  Besides rats, 
muscimol is also neuroprotective in rabbits (Lyden and Hedges, 1992) and 
gerbils (Shuaib et al., 1993).  Muscimol shows synergistic effects when given in 
combination with baclofen (Costa et al., 2004; Xu et al., 2008) and MK-801 
(Lyden et al., 2000; Lyden and Lonzo, 1994).  More importantly, muscimol is 
neuroprotective when given before (Han et al., 2008; Xiao et al., 2007; Xu et al., 
2008; Zhang et al., 2007; Zhou et al., 2008), during (within 5 min of ischemic 
onset) (Lyden and Hedges, 1992; Lyden and Lonzo, 1994), and even within 4 h 
after the ischemic onset (Lyden et al., 2000).  It is known that most of the 
GABAmimetic drugs, like pentobarbitone, diazepam and baclofen are 
neuroprotective when administered before ischemic insults but not effective when 
administered after ischemia.  The exceptions are muscimol and Clomethiazole 
(CMZ), which show neuroprotection even after ischemia (Cross et al., 1991).  In 
fact, there is no evidence that neuroprotection for acute ischemic stroke is 
possible with any agent beyond 6 h.  Even within the 6 h, the extent of 
neuroprotection with any agent is likely to decline with increasing delay to 
administration (Ginsberg, 2008).  Since muscimol enters the blood brain barrier 
in concentrations that can elicit a persistent GABAmimetic effect (Baraldi et al., 
1979),  previous studies have shown that both intraventricular (from Lyden’s 
group) or intraperitoneal injection (from Zhang’s group) of muscimol work well.   
The side effect that should be taken into account for all the GABAmimetic drugs 
is that they sedate the experimental animals and brings down cerebral 
temperature, which might be neuroprotective after ischemia.  Since the 
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temperature was closely monitored in the studies from Zhang’s group (Han et al., 
2008; Xiao et al., 2007; Xu et al., 2008; Zhang et al., 2007; Zhou et al., 2008), the 
neuroprotective effects should come from muscimol’s GABAmimetic effects.   
One other GABAmimetic drug, CMZ, which is also a GABAA receptor 
agonist, was extensively studied by the group headed by Green (Green, 1998).  
CMZ is found to be neuroprotective in animal models by functional, biochemical 
and histological measures.  It finally went to the clinical trials.  The lack of 
beneficial effect on long-term outcome for all the patients stalls its further clinical 
studies (Lyden et al., 2001; Wahlgren et al., 1999).  The other GABAmimetic 
drug that was translated from animal studies to clinical trials was Diazepam, a 
benzodiazepine agonist, which showed no promising effects in stroke patients as 
CMZ (Lodder et al., 2006).   
Some GABAmimetic drugs increase the synaptic concentration of GABA 
by inhibiting the reuptake of GABA, like Topiramate, or inhibiting GABA-
transaminase, like Vigabatrin.  Animal studies revealed no significant 
neuroprotective effects of these drugs in ischemia by functional and histological 
measures (Madden et al., 2003).   
The failure of these translational studies could be explained by many 
factors as mentioned in the previous paragraph.  It could also be explained by 
several other possibilities considering from different angles.  One is that the 
functions of postsynaptic GABAA receptors are depressed after ischemia.  It is 
known that GABAA responses are very sensitive to intracellular ATP levels 
(Shirasaki et al., 1992).  Decreased ATP production after ischemia induces a 
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selective and rapid rundown of the postsynaptic GABAA responses (Harata et al., 
1997).  Other outcomes induced by ischemia, like calcium overload and the 
production of arachidonic acids, also depress GABAA receptor functions 
(Schwartz et al., 1992).  Therefore, there is very little space left for GABAA 
receptor agonists to activate these functionally depressed GABAA receptors after 
ischemia.   
The second is that large accumulation of GABA in the extracellular space 
has been demonstrated by in vivo and in vitro studies during cerebral ischemia 
and early after reperfusion (Allen et al., 2004; Globus et al., 1988; Phillis et al., 
1994).  Further application of the GABAmimetic drugs to increase the 
extracellular GABA concentration might have little effect to potentiate GABAergic 
activity.   
The third is that after ischemia, the intracellular concentration of chloride 
might have increased to the extent that further potentiation of GABA activity 
results in excitatory effects, due to the more depolarized chloride reversal 
potential relative to the resting membrane potential.   Thus, the activation of 
GABAA receptors becomes excitotoxic.  Studies have shown that chloride 
concentration is increased in hippocampal neurons after in vitro ischemia.  
Activation of GABAA receptors (Inglefield and Schwartz-Bloom, 1998b), 
downregulation of K+-Cl-cotransporters (KCC2) (Galeffi et al., 2004) or activation 
of Na+-K+-Cl- cotransporters (NKCC1) (Pond et al., 2006) has been suggested to 
be involved in the increase.  All these possibilities make the translational studies 
more complicated than what we have imagined.  
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Remarks: 
Overall, potentiation of inhibitory synaptic transmission by GABAmimetic drugs is 
neuroprotective in animal studies after ischemia.  However, the failure of the 
translational studies suggests that more factors should be taken into account 
before we finally reach the goal. 
Presynaptic GABAA receptors’ role in the modulation of neurotransmitter 
release 
Presynaptic ionotropic receptors are very important in the modulation of 
presynaptic neurotransmitter release.  The small changes in membrane potential 
and input resistance induced by the activation of presynaptic ionotropic receptors 
have substantial effects on synaptic strength and information processing 
(Engelman and MacDermott, 2004).  Presynaptic GABAA receptors are of great 
interest to us since they could be inhibitory or excitatory depending on the 
intracellular chloride concentration and the shunting effect.  The intracellular 
chloride concentration could be modulated during brain maturation and under 
disease condition.   
Previous studies have found GABAA receptors on the axons of many cell 
types, such as hippocampal granule cells (Jang et al., 2006b; Ruiz et al., 2003), 
cerebellar molecular interneurons (Pouzat and Marty, 1999), cortical pyramidal 
neurons (Szabadics et al., 2006), calyx of Held (Turecek and Trussell, 2002), 
horizontal cells in the retina (Kamermans and Werblin, 1992), and dorsal root 
ganglia neurons (Eccles, 1964; Rudomin and Schmidt, 1999).  Presynaptic 
GABAA receptors have been reported on the glutamatergic (heterosynaptic) 
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(Jang et al., 2006b; Ruiz et al., 2003; Stell et al., 2007), glycinergic 
(heterosynaptic) (Jang et al., 2002), and GABAergic (homosynaptic) terminals 
(Axmacher and Draguhn, 2004; Xiao et al., 2007).  In mature animals, the effects 
on the activation of these presynaptic GABAA receptors vary from inhibition 
(Axmacher and Draguhn, 2004; Eccles, 1964) to excitation  (Jang et al., 2001; 
Jang et al., 2002; Jang et al., 2006b; Stell et al., 2007; Turecek and Trussell, 
2002; Xiao et al., 2007) depending on different tissues and preparations. 
The main mechanism for the excitatory effects of presynaptic GABAA 
receptor activation is the high chloride concentration at the terminals.  The 
chloride concentration in the terminals might be different from that of the soma.  
In the mammalian central nervous system, the calyx of Held has a higher 
chloride concentration than that in the soma as demonstrated by perforated-
patch recording (Price and Trussell, 2006; Turecek and Trussell, 2001).  Thus, 
following the activation of presynaptic GABAA receptors, there will be a chloride 
efflux and depolarization in the presynaptic terminals.  If the depolarization 
exceeds the shunting effects caused by GABAA receptor activation, voltage-
gated sodium and calcium channels will be activated and neurotransmitter 
release occurs (Jang et al., 2006a; Jang et al., 2001; Leinekugel et al., 1995; 
Xiao et al., 2007).  However, there are also studies showing that GABAA 
receptor-induced rises in the intracellular calcium concentration is driven by 
osmotic tension (Chavas et al., 2004).  If the shunting effects could not be 
exceeded, the excitability of presynaptic terminals will be inhibited (Cattaert and 
El Manira, 1999; Ruiz et al., 2003).  In addition, the depolarization-induced 
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inactivation of sodium channels will reduce the excitability of the terminals 
(Graham and Redman, 1994; Zhang and Jackson, 1993).   
The other inhibitory neurotransmitter in the nervous system is glycine.  
Presynaptic glycine receptors have been found on the calyceal synapses in the 
medial nucleus of trapezoid body, the activation of which depolarizes the 
terminals, activates calcium channels and increases glutamate release (Turecek 
and Trussell, 2001).  The glycine receptors are also found on the GABAergic 
terminals synapsed on the dopaminergic neurons in the ventral tegmental area, 
the activation of which results in hyperpolarization and a decrease in GABA 
release (Ye et al., 2004). 
In the immature neurons, GABAA and glycine receptors are excitatory 
(Rivera et al., 1999).  Activation of presynaptic GABAA or glycine receptors 
results in increased GABA release in the immature dopaminergic neurons of 
ventral tegmental area in the immature rats (Xiao et al., 2007; Ye et al., 2004).  
Activation of presynaptic glycine receptors enhances both excitatory and 
inhibitory synaptic transmission in the immature cerebellar Purkinje neurons 
(Kawa, 2003).  Activation of presynaptic GABAA receptors results in increased 
glutamate release on the ventromedial hypothalamic neurons in the immature 
rats (Jang et al., 2001).  The high expression level of NKCC1, an inwardly 
chloride transport system, are believed to be responsible for the high intracellular 
chloride concentration in the immature animals (Plotkin et al., 1997). 
Besides the immature neurons, neurons under disease conditions, like 
ischemia and epilepsy, have high intracellular chloride concentration.  After in 
22 
 
vitro ischemia, studies have shown that intracellular chloride concentration is 
increased in hippocampal neurons.  Activation of GABAA receptors (Inglefield 
and Schwartz-Bloom, 1998b) and NKCC1 (Pond et al., 2006), or downregulation 
of KCC2 (Galeffi et al., 2004), has been suggested to be involved in the increase.  
After pilocarpine-induced status epilepticus, dentate granule cells have increased 
chloride concentration and increased excitability due to the decreased 
expression of KCC2 (Pathak et al., 2007). 
Remarks: 
GABAA receptors are located on central and peripheral terminals.  They are 
actively involved in the modulation of neurotransmitter (including glutamate, 
glycine and GABA) release.  The modulation effects could be varied from 
inhibitory to excitatory upon the activation of presynaptic GABAA receptors, 
depending on the driving force for chloride and shunting effects.  Intracellular 
chloride concentration varies on the maturation states and different disease 
states, resulting in different modulating effects on the excitability of the 
presynaptic terminals and neurotransmitter release.  
Summary 
LA neurons are the only non-GABAergic neurons in the striatum.  They receive 
inhibitory inputs from MS neurons.  After transient cerebral ischemia, LA neurons 
survive while MS neurons die.  Previous studies have shown that differential 
changes in the intrinsic membrane properties and excitatory synaptic 
transmission play a role in this selective vulnerability.  However, the role of 
inhibitory synaptic transmission in this selective vulnerability is still unknown.  
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Since inhibitory tone is very important in the control of neuronal excitability, the 
present study is aimed at examining if there are any changes in inhibitory 
synaptic transmission in striatal neurons after ischemia and the possible 
mechanisms.  We also examined if facilitation of inhibitory synaptic transmission 
by muscimol could attenuate ischemic neuronal injury in the striatum after 
ischemia.  Results from this study will improve the understanding of the 
mechanisms underlying selective neuronal injury after transient cerebral 
ischemia.  We hope this study could contribute to the translational studies for the 
stroke patients after cardiac arrest.  
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HYPOTHESIS AND EXPERIMENTAL DESIGN 
Hypothesis 1: It is widely accepted that excitotoxicity, triggered by excessive 
glutamate release, is the major cause for postischemic cell death.  Since LA 
neurons survive ischemic insults, it is reasonable to speculate that they have 
their own way to defend excitotoxicity.  It has been shown that excitatory synaptic 
transmission is facilitated in MS neurons (Zhang et al., 2005) while it is 
depressed in LA neurons (Pang et al., 2002) after transient forebrain ischemia.  
This suggests that differential changes in the excitatory synaptic transmission 
after ischemia might contribute to the selective neuronal death in the striatum.  
Inhibitory synaptic transmission is an important source counteracting excitatory 
synaptic transmission.  In addition, GABAergic synaptic transmission provides an 
important tone in the control of neuronal excitability.  Potentiation of inhibitory 
synaptic transmission might contribute to the postischemic neuroprotection since 
its contribution to the decrease of excitotoxicity by counterbalancing the 
excitability.  Ample evidence has demonstrated that GABAmimetic drugs are 
neuroprotective after ischemia as we have discussed in the introduction.  
Therefore, we hypothesized that inhibitory synaptic transmission is enhanced in 
ischemia-resistant LA neurons after ischemia.  To study the change of inhibitory 
synaptic transmission in LA neurons after ischemia, evoked IPSCs will be 
examined.   
Hypothesis 2: Studies have shown that postsynaptic GABAA responses are 
depressed after ischemia.  Cellular mediators that depress GABAA receptor 
function, such as arachidonic acid and superoxide radicals, were released after 
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cerebral ischemia (Patel et al., 1992; Rao et al., 1999).  Intracellular calcium 
overload (Inoue et al., 1986; Stelzer et al., 1988) also contributed to the 
decreased conductance of GABAA receptor.  GABAA responses are very 
sensitive to intracellular ATP levels (Shirasaki et al., 1992) and decreased ATP 
production after ischemia induces a selective and rapid rundown of the 
postsynaptic GABAA responses (Harata et al., 1997).  In addition, GABAA 
receptors were down regulated in the hippocampus and striatum after cerebral 
ischemia (Alicke and Schwartz-Bloom, 1995; Mileson et al., 1992; Onodera et al., 
1987).  Therefore, we hypothesized that presynaptic components contribute to 
the enhancement of evoked IPSCs in LA neurons after ischemia.  To test this 
hypothesis, paired-pulse test, miniature IPSCs analysis will be performed and 
exogenous GABA will be applied.   
Hypothesis 3: GABAA receptors could be excitatory or inhibitory depending on 
two factors.  One is the difference between the resting membrane potential and 
chloride reversal potential, the latter of which is mainly dependent on the 
intracellular concentration of chloride. The other is the shunting effect.  Studies 
have shown that intracellular chloride concentration is increased after ischemia, 
which might change the effects of activating GABAA receptors from inhibitory to 
excitatory.  It is well known that presynaptic GABAA receptors are actively 
involved in the modulation or presynaptic neurotransmitter release.  We 
hypothesized that presynaptic GABAA receptors increase presynaptic GABA 
release due to their excitatory effects after ischemia.   To test this hypothesis, 
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muscimol’s effect on evoked IPSCs, spontaneous and miniature IPSCs will be 
compared before and after ischemia. 
To examine if muscimol could protect striatal neurons from ischemic 
injury, muscimol will be applied intraperitoneally to the rats at 30 min before 
ischemia.  The reason we administered muscimol at 30 min before ischemia is 
that most of the agents show neuroprotection when given before ischemic 
insults.  The extent of neuroprotection with any agent is likely to decline with 
increasing delay to administration (Ginsberg, 2008).  Ischemic neuronal injury will 
be estimated by counting the survived cells in the striatum.   
Hypothesis 4: LA neurons receive inhibitory inputs from MS neurons.  As early 
as 6 h after transient cerebral ischemia, MS neurons in the dorsolateral part 
show visible damage and most of them die in 24 h.  Therefore, we hypothesized 
that the GABAergic innervations to LA neurons is decreased after ischemia due 
to the massive degeneration of MS neurons.  To test this hypothesis, 
immunoreactivity of GAD65 will be examined in the striatum before and after 
ischemia.  Western blotting will also be used to examine the expression level of 
GAD65 after ischemia. 
Experimental design: 
1. To compare the inhibitory synaptic transmission in LA neurons before and 
after ischemia.   
Four-vessel occlusion model will be used to induce transient forebrain 
ischemia.  Using the whole-cell voltage-clamp recording on the brain slices, the 
evoked IPSCs will be compared in LA neurons and MS neurons before and at 
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different time intervals after ischemia.  Animals are divided into three groups: 
control, 3 h, and 24 h after ischemia.  At 3 h after ischemia, most of the striatal 
neurons are morphologically intact and functional.  By contrast, at 24 h after 
ischemia, most of the MS neurons in the dorsolateral striatum degenerate 
(Pulsinelli et al., 1982).  Striatal slices in the thickness of 300 μm will be prepared 
from the control and postischemic rats.  LA neurons and MS neurons are visually 
identified by their soma size under infrared-DIC microscope.   
Inhibitory synaptic transmission is pharmacologically separated from 
excitatory synaptic transmission by using the NMDA receptor antagonist D-APV 
(50 μM), and the non-NMDA receptor antagonist CNQX (10 μM).  GABAB 
receptors are also expressed in the striatum (Misgeld et al., 1995).  Inclusion of 
QX-314 in the internal solution, which blocks GABAB receptors besides sodium 
currents (Andrade, 1991), assures that we are recording only GABAA receptor-
mediated synaptic transmission in the postsynaptic neuron.  IPSC will be evoked 
intrastriatally with the stimulating electrode being positioned around 150-200 μm 
close to the recording electrode.  LA neurons are held near their resting 
membrane potential, –60 mV (Bennett et al., 2000).  To set up the I-V curve 
before and after ischemia, LA neurons are held under different holding potentials 
and evoked IPSCs will be recorded.  Recording condition for evoked IPSCs in 
MS neurons will be the same except that MS neurons are held at -70 mV.  The 
amplitude of evoked IPSCs will be compared before and after ischemia.  After 
successful recordings, some of the neurons will be identified by intracellular 
staining with neurobiotin.   
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2. To determine the involvement of pre- and/or postsynaptic mechanisms in 
the alteration of inhibitory synaptic transmission after ischemia.  Paired-pulse test, 
miniature and spontaneous IPSCs analysis will be performed and exogenous 
GABA will be applied to LA neurons before and after ischemia to identify the pre- 
and/or postsynaptic mechanisms. 
Paired-pulse stimulation, in which the synapses are activated twice with a 
short interval, induces two forms of short-term synaptic plasticity: paired-pulse 
facilitation (PPF) and paired-pulse depression (PPD).  Paired-pulse protocol is 
one of the most widely used approaches to assess the synaptic sites of effects 
on synaptic transmission.  At most synapses, an increase of presynaptic release 
probability decreases the magnitude of PPF, increases the magnitude of PPD.  
Conversely, a decrease of presynaptic release probability increases the 
magnitude of PPF, decreases the magnitude of PPD.  Thus, it is widely accepted 
that a change in PPF and PPD after experimental manipulations is indicative of 
the involvement of presynaptic mechanisms, especially the presynaptic release 
probability.  In this experiment, two successive stimuli with an interval of 50 ms 
will be given by bipolar tungsten electrode.  Paired-pulse ratio (PPR), which is 
the ratio of the second current amplitude to the first one, will be compared before 
and after ischemia.   
Miniature IPSCs result from spontaneous, action potential-independent 
release of GABA from presynaptic GABAergic terminals.  Each miniature event is 
believed to be caused by the release of a single vesicle/quantum.  The frequency 
of miniature IPSCs is determined by two factors.  One is the total number of 
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presynaptic axon terminals that synapse on the postsynaptic neurons; the other 
is the release probability at each individual synapse.  Therefore, it is widely 
accepted that changes in the frequency reflect presynaptic site of effects 
(Edwards et al., 1990).  The mean amplitude of miniature IPSCs, also called 
quantal size, is the response of the postsynaptic receptors to the spontaneous 
release of a single vesicle.  For most of the central synapses, transmitters from a 
single vesicle are enough to saturate postsynaptic receptors.  The number and 
properties of postsynaptic receptors determine quantal size (Nusser et al., 1997).  
Therefore, changes in the mean amplitude of miniature IPSCs suggest 
postsynaptic site of effects.  For miniature IPSCs recording, TTX (1μM) will be 
applied to block the action potential-mediated IPSCs.  An episode of 5-10 min 
miniature IPSCs will be collected before and after ischemia.  The frequency and 
amplitude of miniature IPSCs will be compared before and after ischemia.   
A change in the function or number of postsynaptic GABAA receptors 
might contribute to the alteration of synaptic strength.  To test this possibility, 
exogenous GABA application (300 μM) will be performed to observe the 
postsynaptic response.  The solutions will be applied through a Y tube system by 
gravity.  The tip of the Y tube has a diameter between 100 µm and 150 µm and 
will be placed close to the recording electrode on the brain slice surface.  The 
duration for GABA application is 10 s.   
3. To examine the effects of muscimol on inhibitory synaptic transmission 
after ischemia.  To examine if muscimol treatment could protect striatal neurons 
from ischemic injury.   
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Whole-cell patch-clamp recordings are performed on LA neurons on brain 
slices.  Muscimol, at the concentration of 1 μM, is applied via the bath perfusion.  
Evoked IPSCs, PPR, miniature, and spontaneous IPSCs will be compared in the 
control LA neurons and LA neurons at 24 h after ischemia, before and after 
muscimol application.  To reveal the role of calcium in muscimol’s action, 
spontaneous IPSCs will be recorded before and after muscimol application in the 
Ca2+-free solution. 
Muscimol (1 mg/kg) will be injected intraperitoneally at 30 min before 
ischemia.  After paraffin embedding, striatal slices in the thickness of 10 μm will 
be cut.  After hematoxylin & eosin (HE) staining, ischemic neuronal injury will be 
estimated by counting the survived cells in the striatum.   
4. To investigate the changes of GAD after ischemia.   
GAD Immunoreactivity will be compared in the striatum before and after 
ischemia by immunohistochemical studies.  Western blotting will be used to 
quantify GAD protein expression before and after ischemia. 
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MATERIALS AND METHODS 
Male Wistar rats of 200-250 g (Charles River Laboratories, Wilmington, MA), with 
an approximate age of 6-7 weeks (mature synapse function) (Ben-Ari, 2001), 
were used in the present study.  Experimental protocols were institutionally 
approved in accordance with the National Institutes of Health Guide for the Care 
and Use of Laboratory Animals.  We made our efforts to minimize both the 
suffering and number of animals used. 
Animal models of transient forebrain ischemia 
Four-vessel occlusion was used to induce transient forebrain ischemia (Pulsinelli 
and Brierley, 1979) with modifications (Ren et al., 1997).  The rats were fasted 
overnight to provide uniform blood glucose levels.  During the surgery, the 
animals were anesthetized with a mixture of 1-2% halothane in 33% oxygen and 
66% nitrogen via a nasal mask.  The silicon tubing (0.025" I.D., 0.047" O.D.) was 
placed underneath each common carotid artery and passed through the two 
holes in a small Teflon button.  With a plastic cylinder, a loop was formed loosely 
around each common carotid artery and a suture line was tied at the end of the 
loop to allow subsequent occlusion of these vessels.  The vertebral arteries were 
then electrocauterized.  Following craniectomy, a temperature probe (0.025" 
diameter, Physitemp, Clifton, NJ) was placed underneath the skull and the brain 
temperature was maintained at 36.5 ˚C with a heating lamp (BAT-10, Physitemp, 
Clifton, NJ).  A glass microelectrode (5-8 μm in diameter of the tip) filled with 2 M 
NaCl was advanced 3.0 mm below the dura mater into the striatum.  When 
performing the occlusion, the silicone tubing was pulled through the cylinder, 
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compressing the artery against the Teflon button (Figure 4).  Ischemic 
depolarizations (DC potential shifts from 0 mV to about -20 mV), recorded by a 
neuroprobe amplifier (Model 1600, A-M systems, Carlsborg, WA), occurred 
approximately 2-3 min after the occlusion.  The occlusion lasted for 20 min.  
Upon release of the tubing, cerebral blood flow resumed immediately but it took 
about 1-2 min for the DC potential to return to 0 mV (Figure 5).  
Our ischemia model has the following advantage and disadvantage.  The 
advantage is that this model better mimics stroke patients in the clinics since 
ischemia is performed in vivo.  For in vitro ischemia model, the microenvironment 
surrounding neurons is artificially controlled by experimenters.  Though easier to 
perform, the pathological process might be different from what observed in the 
patients.  The disadvantage is that we used relatively young rats to yield better 
quality of the brain slices for recording while most of the stroke patients are old 
and always have some other cardiovascular diseases. 
Slice preparation and whole-cell voltage-clamp recording 
Brain slices were harvested from control rats and the rats at 3 h, 8 h, and 24 h 
after ischemia as previously reported (Pang et al., 2002).  The rat was deeply 
anesthetized with the Ketaset and then perfused transcardially with the cold 
sucrose solution oxygenated with 5% CO2 and 95% O2.  The composition of the 
sucrose solution was as follows (in mM): Sucrose 230; NaHCO3 26; KCl 2.5; 
NaH2PO4 1.25; CaCl2 0.5; MgSO4 10; Glucose 10.  The rat was then decapitated 
and the brain was quickly removed from the skull.  Coronal striatal slices (300 μm) 
were cut using a vibratome (Leica VT1000, Leica Microsystems Gmbh, 
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Heidelberg, Germany) in the ice-cold sucrose solution.  The slices were then 
incubated in the artificial cerebrospinal fluid (aCSF) equilibrated with 95% O2 and 
5% CO2 for 30 min at 34 ˚C before being returned to room temperature.  The 
aCSF was comprised as the following (in mM): NaCl 130; KCl 3; CaCl2 2; MgCl2 
2; NaH2PO4 1.25; NaHCO3 26; Glucose 10.  
The electrodes for whole-cell voltage-clamp recordings were prepared 
using a horizontal micropipette puller (Framing/Brown 97, Sutter, Novato, CA) 
from the borosilicate glass capillaries (Warner, Hamden, CT).  The internal 
solution contained (in mM): CsCl 43; CsMeSO4 92; TEA 5; EGTA 2; MgCl2 1; 
HEPES 10; QX314 3 and Mg-ATP 4.  The internal chloride concentration of 50 
mM and the extracellular chloride concentration of 141 mM yield a chloride 
reversal potential of -28 mV at 30 ˚C by Nernst equation.  The inclusion of QX314 
blocked the voltage-dependent sodium channels and GABAB receptor activated 
potassium conductance (Andrade, 1991).  The pipette resistance was 2-4 MΩ 
using this internal solution.  Recordings were performed under an infrared-DIC 
microscope (BX50WI, Olympus, Tokyo, Japan) and a CCD camera in the aCSF 
at 30-32 ˚C (SF-28 in-line heater, Warner, Hamden, CT).  The flow rate was 
adjusted to 2-3 ml/min.  After the high-resistance seal (>1 GΩ) was formed, a 
negative pressure was used to rupture the membrane to obtain the whole-cell 
configuration. Recordings were made using Axopatch 200B (Molecular Devices, 
Sunyvale, CA).   
LA neurons were held at –60 mV.  Signals were filtered at 1-5 KHz and 
sampled at 5-10 KHz for on-line and later off-line analysis by the data acquisition 
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program Axograph 4.9 (Molecular Devices, Sunyvale, CA).  Intrastriatal 
stimulation was evoked by using the bipolar tungsten electrodes (~5 MΩ, Micro 
Probe, Potomac, MD).  The stimulus electrode was positioned 150-200 µm 
subjacent to the recording electrode (Figure 6).  Isolated stimulator (ISO-Flex, 
AMPI, Israel) sent out electrical currents with the pulse width of 100 µs every 5 
sec (frequency=0.2 Hz) (Master-8, A.M.P.I., Israel).  The threshold of stimulus 
intensity was determined when the amplitude of evoked inhibitory postsynaptic 
currents just appeared.  Since a submerged chamber and the bipolar stimulating 
electrodes were used, the currents delivered from the stimulator may not 
represent the currents passing the tissue.  Thus, we normalized the stimulus 
intensity as 2 times of the threshold (2T), 3T, 4T etc.  For the paired-pulse 
stimulation, 3T was always used and the interval between the two stimuli was 50 
ms.  Only monosynaptic transmission with consistent onset latencies was 
collected for data analysis.  Access resistance was monitored throughout the 
recording, and cells that demonstrated the access resistance below 20 MΩ were 
included in the analysis.  An episode of 5-10 min was collected for miniature 
IPSCs and spontaneous IPSCs.  Tetrodotoxin (TTX, 1 μM) was applied during 
miniature IPSCs recording.  Axograph 4.9 was used to detect and measure the 
amplitude and inter-event intervals of the synaptic events.  IPSCs above a 
threshold (4.5-5.5 SDs above baseline noise) were automatically detected by a 
sliding template algorithm and manually checked off-line.  For the Ca2+-free 
solution, CaCl2 was removed from the aCSF and 2 mM ethylene glycol 
tetraacetic acid (EGTA) was added. 
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γ-aminobutyric acid (GABA), ()-bicuculline methiodide (BMI), DL-2-
amino-5-phosphonopentanoic acid (D-APV), 6-cyano-7-nitroquinoxaline-2, 3-
dione disodium (CNQX), TTX and muscimol were purchased from Sigma (St. 
Louis, MO).  Neurobiotin was purchased from Vector (Burlingame, CA).  Drugs 
were dissolved in the aCSF and applied through bath perfusion except that 
GABA was applied through a Y tube system.   
Intracellular staining of neurons with neurobiotin 
Neurobiotin (1%) was included in the internal solution for intracellular labeling of 
some recorded neurons before HRP reaction.  After successful recordings, 
neurobiotin was delivered into the cell by passing depolarizing pulses for about 5 
min.  The slice was placed in 4% paraformaldehyde (pH=7.4) at 4 ˚C overnight.  
Then, the slice was incubated in 0.1% peroxidase-conjugated avidin-D in KPBS 
(pH=7.4) with 0.5% Triton X-100 for 6-8 h at room temperature.  Subsequently, 
the slice was detected with diaminobenzidine (DAB). 
Immunohistochemistry 
Under deep anesthesia, the rats were transcardially perfused with heparinized 
saline followed by 4% paraformaldehyde in 0.15 M NaPBS.  The brains were 
removed and post fixed in the same fixative at 4 ˚C overnight.  They were then 
cryoprotected in 30% sucrose in 0.1 M phosphate buffer (Ph=7.4) for at least 48 
h.  The brains were frozen in the embedding medium (O.C.T., Sakura Finetek, 
Torrance, CA) on dry ice for at least half an hour before they were transferred to 
the cryostat.  Coronal sections of 30 μm were cut and kept in the cryoprotective 
36 
 
buffer at -20 ˚C.  The cryoprotective buffer was composed of the following (V/V): 
ethylene glycol (20%), glycerol (30%), 0.01M KPBS (50%).   
For immunofluorescence studies, free-floating sections were rinsed in 
0.01M KPBS three times and then incubated in the blocking serum (5% normal 
horse serum in 0.01 M KPBS with 0.5% Triton X-100) for 1 h at room 
temperature.  After that, they were incubated with rabbit anti-GAD65 (1:500; 
Millipore, AB5082; Bedford, MA), in the blocking serum overnight at room 
temperature.  After three washes in KPBS, they were incubated in the secondary 
antibody solutions, Fluorescein goat anti-rabbit IgG (1:100; Vector, FI-1000; 
Burlingame, CA) for two hours.  Following three washes, they were mounted on 
slides and cover slipped with vectashield (Vector, H-1000) for fluorescence 
observation.  Images were taken with a CCD camera installed on the Olympus 
BX50 microscope. 
Some of the sections were mounted on slides for standard HE staining.  
For the Avidin-Biotin Complex (ABC) reactions, the procedures were the same as 
those in the doublelabeling immunofluorescence mentioned above except 
different secondary antibodies were used and the reaction products were 
revealed with DAB and H2O2.  Besides rabbit anti-GAD65, other primary 
antibodies used were: mouse anti-vesicular glutamate transporter 2 (anti-
vGLUT2; 1:1000; Millipore, MAB5504) and mouse anti-GAD67 (1:2000; Millipore, 
MAB5406).   
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Western blotting 
The control rats and rats at 1 day and 3 days after ischemia were sacrificed and 
the brain slices containing striata were cut at the thickness of 600 μm.  Striata 
were dissected out and stored on the dry ice before they were manually 
homogenized using ice-cold radioimmunoprecipitation assay buffer (10 mg 
tissue/100 ml buffer, Boston Bioproducts, Worcester, MA) supplemented with 
proteinase inhibitors (Roche, Indianapolis, IN).  After sonication, the lysates were 
centrifuged at 14,000 g for 20 min at 4 ˚C.  Supernatants were collected for 
further analysis.  Bicinchoninic acid protein assay (Bio-Rad Protein Assay, Bio-
Rad Laboratories, Inc., Hercules, CA) was used to determine the protein 
concentration.  The final concentration of the protein sample was adjusted to 1 
μg/ml in the 2×SDS gel-loading buffer (Invitrogen, Carlsbad, CA).  The protein 
samples were denatured by boiling before being loaded (20 μg) on the 10% 
SDS-polyacrylamide gel.  After separation on the gel, the proteins were 
transferred to the nitrocellulose membranes (Millipore).  The membranes were 
then blocked with 0.1% bovine serum albumin in Tris-buffered saline containing 
0.1% Triton-X for 1 h at room temperature.  They were then incubated either in 
the mouse anti-actin (1:20,000, Sigma) or the rabbit anti-GAD65 (1:6,000, 
Millipore) antibodies in the blocking buffer at 4 ˚C overnight.  After three washes, 
the membranes were incubated in the secondary antibody: peroxidase labeled 
anti-mouse (1:30,000, Millipore) IgG or peroxidase labeled anti-rabbit (1:100,000, 
Millipore) IgG for 1 h at room temperature.  The corresponding bands were 
detected with the enhanced chemiluminescence (Amersham Pharmacia Biotech, 
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Piscataway, NJ) and visualized by exposing the membrane to autoradiography 
films (Fuji, Tokyo, Japan).  Data analysis was performed by using the software 
ImageJ from NIH. 
Drug administration and sample preparation for paraffin embedding 
Muscimol (Enzo Life Sciences International, Plymouth Meeting, PA) was 
dissolved in saline at 0.5 mg/ml.  At 30 min before ischemia, muscimol (1mg/kg) 
(Costa et al., 2004) was given to the rats intraperitoneally.  One day after 
ischemia, the rats were deeply anesthetized with the Ketaset and then 
transcardially perfused with 0.01 M NaPBS (pH=7.4) followed by the fixative 
(10% acetic acid, 10% formaldehyde (37%) and 80% methanol).  The brain 
stayed in situ overnight.  The next day, the brain was removed and post fixed in 
4% paraformaldehyde for several days before it was transferred to 70% ethanol 
for 1-2 days.  Then they were sent for paraffin embedding by a specialist.   
Quantification analysis of the terminals in the striatum 
Quantification analysis was performed by an investigator who was blinded to the 
treatments using the software ImageJ (NIH).  Images were captured from 
dorsolateral and dorsomedial striatum from 3 interaural planes corresponding to 
10.6, 8.7, and 8.08 mm. 
To analyze the optical density of presynaptic terminals for GAD65, images 
were captured in black and white 8-bit grayscale under 100× using a CCD 
camera from DAB stained sections.  The density of the terminals was determined 
in fixed regions measuring 1×1 mm2 that was kept constant across all of the 
images.  The pixels were converted to square millimeters by employing a 
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calibration that converts pixels to millimeters.  The density in the white matter, 
such as corpus callosum and striatal fibers, was subtracted as the background.  
The final numeric value represented the optical density of the terminals in each 
mm2.  A mean was calculated for each animal and a total mean±SEM was 
determined for each experimental treatment group. 
To obtain the information of terminal number, size and intensity, images 
were taken from sections after doublelabeling immunofluorescence in black and 
white 8-bit grayscale under 400× using a CCD camera.  Thresholding was 
performed to distinguish the object terminals from the background.  After precise 
thresholding, the minimum and maximum size of the terminals was set to occlude 
the objects clearly not of interest.  A mean was calculated for each animal and a 
total mean±SEM was determined for each experimental treatment group. 
Quantification analysis of survived cells in the striatum 
Quantification analysis was performed by an investigator who was blinded to the 
treatments.  After paraffin embedding, coronal sections of 10 μm were cut and 
three interaural planes in the striatum, corresponding to 10.6, 8.7, and 8.08 mm, 
were selected.  Four consecutive sections were taken from each plane for HE 
staining.  Dorsolateral and dorsomedial striatum were randomly selected in each 
hemisphere of a section by light microscopy under 200×.  Dead cells showed 
shrunken nuclei while survived cells remained normal morphology.  We assessed 
ischemic neuronal damage by counting survived cells.  48 microscopic fields 
(400×300 μm) were used to count survived cells in the dorsal part of the striatum 
in both hemispheres for each rat. 
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Data analysis 
Numerical data were expressed as mean±SEM.  Unpaired or paired two-tailed 
Student’s t-tests were applied using the Statview (Statview, Abacus Concepts, 
Cary, NC).  The amplitudes and inter-event intervals of miniature IPSCs and 
spontaneous IPSCs from a single neuron were examined by constructing the 
distributions of cumulative probability and the Kolmogorov-Smirnov (K-S) tests 
were used to detect the difference.  P<0.05 was considered statistically 
significant. 
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RESULTS 
Selective neuronal death in the striatum 
To reveal whether the four-vessel occlusion model used in this project 
reproduces the selective neuronal death in the striatum, we used HE staining to 
examine striatal neurons.  In control animals, most of the striatal cells were 
medium-sized, possibly MS neurons and GABAergic interneurons (Figure 7A).  
Only a few of the striatal cells were large-sized, possibly LA neurons.  At 3 h after 
ischemia, most of the striatal cells showed normal morphology (Figure 7B).  But 
at 24 h and 72 h after ischemia, very few striatal cells remained normal 
morphology, in which some of them are LA neurons as indicated by the size 
(arrows, Figure 7C-D).  Most of the cells exhibited pyknotic and shrunken nuclei, 
the identity of which is difficult to tell. They could be MS neurons or GABAergic 
interneurons with pyknotic and shrunken nuclei, or the activated glial cells.  
Although we can identify the normal morphology of the survived cell by HE 
staining, we could not tell whether the cells with abnormal morphology are dead 
or not.  We could not tell whether they are undergoing necrosis or apoptosis 
either.  Previous research from this group have demonstrated that MS neurons 
undergo both necrosis and apoptosis after transient cerebral ischemia by EM 
studies (Ruan et al., 2003).  The combination of several specific biochemical 
analyses is needed to identify the type of cell death (Kroemer et al., 2009).  
Therefore, from the HE staining, we conclude that the large-sized neurons, 
corresponding to the LA neurons, survive at 24 h after ischemia (Figure 7).   
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Identification of striatal neurons 
Whole-cell voltage-clamp recordings were performed on striatal neurons.  LA 
neurons were identified by their large soma size (25-60 μm in diameter) (Figure 8, 
10A).  But due to their scarcity, less than five LA neurons could be found on each 
striatal section.  MS neurons were identified by their medium size, 10-15 μm in 
diameter (Figure 9, 10A).  Plenty of MS could be found on each section.  After 
successful recordings, some of the neurons were further confirmed by 
intracellular staining with neurobiotin.  Besides soma size, the main 
morphological difference is that LA neurons have aspiny dendrites and MS 
neurons have spiny dendrites (Figure 8, 9).  LA neurons also have distinctive 
electrophysiological characteristics.  Since the internal solution used contains 
cesium, we could not observe the firing pattern of LA neurons.  But on the first 
two minutes after the cell is broken, sometimes the characteristic firing of LA 
neurons could be recorded.  Upon depolarizing current pulses, LA neurons 
showed prominent afterhyperpolarizations after action potentials.  Injection of 
negative current pulses first produced a hyperpolarization and later a sag in the 
membrane potential as a result of the activation of Ih currents (Jiang and North, 
1991; Kawaguchi, 1993) (Figure 10B).   
Alterations of inhibitory synaptic transmission in LA neurons and MS 
neurons after ischemia 
To examine inhibitory synaptic transmission in LA neurons, evoked inhibitory 
postsynaptic currents were recorded in LA neurons upon intrastriatal stimulation.  
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Intrastriatal stimulation was made by a tungsten electrode positioned about 200 
μm adjacent to the recording electrode (Figure 6).  Threshold intensity was 
determined when the postsynaptic currents just appeared.  Then the intensity 
was increased to two times (2T), 3T, 4T, and 5T of the threshold intensity.  
Intrastriatal stimulation evoked postsynaptic currents from LA neurons containing 
IPSCs mediated by GABAA receptors and excitatory postsynaptic currents 
(EPSCs) mediated by glutamate receptors.  They could be blocked by bicuculline 
(30 μM), or the combination of D-APV (50 μM) and CNQX (10 μM), respectively 
(Figure 10C).  D-APV and CNQX were used routinely to pharmacologically 
isolate GABAergic IPSCs in the subsequent experiments.  At a holding potential 
of -60 mV, inwardly directed evoked IPSCs were elicited.   
To examine if the intracellular concentration of chloride is changed after 
ischemia, we held LA neurons at different potentials (from -100 mV to +20 mV, at 
an increment of 20 mV) and recorded evoked IPSCs at 3T.  The reversal 
potential derived from the I-V curve equals the chloride reversal potential 
calculated by the Nernst equation.  These data indicate that the reversal potential 
of chloride is not changed at 24 h after ischemia (Figure 11), suggesting that the 
intracellular chloride concentration is not changed after ischemia.  However, it 
should be noted that a definitive conclusion cannot be derived using standard 
whole-cell patch clamp recordings:  perforated patch-clamp recordings would be 
able to better address this issue. 
Evoked IPSCs were recorded from LA neurons at 3 h and 24 h after 
ischemia, respectively.  The amplitudes of evoked IPSCs were significantly 
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enhanced after ischemia across the stimulus intensities.  For example, at a 
stimulus intensity of three times of the threshold stimulus intensity (3T), the 
amplitude was enhanced from -47±7 pA in the control (n=12) to -136±30 pA at 3 
h after ischemia (n=9; P<0.05) and -183±30 pA at 24 h after ischemia (n=9; 
P0.05; Figure 12).   
We also recorded evoked IPSCs in MS neurons at 8 h after ischemia.  
Evoked IPSCs in MS neurons were significantly depressed after ischemia (Figure 
13).  For example, at 3T, the amplitude was depressed from -91±14 pA of the 
control level (n=12) to -52±10 pA (n=12; P<0.05; Figure 13) at 8 h after ischemia.   
We observed a significant increase of the stimulus threshold in LA 
neurons after ischemia.  The stimulus threshold was 0.31±0.02 mA for the control 
(n=12), 0.86±0.15 mA (n=9; P<0.01) at 3 h after ischemia, and 0.82±0.19 mA 
(n=9; P0.01; Figure 14A) at 24 h after ischemia.  The threshold also showed 
greater variability after ischemia, ranging from 0.35 mA to 2 mA.   
The increase of the stimulus threshold at 3 h after ischemia indicated that 
the terminals might be functionally damaged even though most of the MS 
neurons were morphologically normal (Figure 7B).  The increase of the stimulus 
threshold means that we need more powerful stimulus to recruit a certain number 
of GABAergic terminals to evoke IPSCs, which is consistent with the decreased 
availability of GABAergic terminals as a result of extensive degeneration of MS 
neurons in the dorsolateral striatum at 24 h after ischemia (Pulsinelli et al., 1982).  
However, this increased stimulus threshold does not mean decreased 
GABAergic transmission.  As the results shown in the next section (Mechanisms 
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for the enhancement of evoked IPSCs in LA neurons after ischemia), the 
frequency of spontaneous IPSCs, recorded without the presence of TTX, was 
increased at 3 h and 24 h after ischemia, highly suggesting that presynaptic 
release is actually increased after ischemia.   
To examine if this increase of evoked IPSCs was resulted from the 
increase of the stimulus threshold, we plotted the absolute values of 3T against 
the amplitudes of evoked IPSCs at 3 h and 24 h after ischemia.  No linear 
correlation was observed in both groups, indicating the increase of evoked IPSCs 
was not due to the increase of the stimulus threshold (Figure 14B). 
Therefore, inhibitory synaptic transmission is significantly enhanced in the 
ischemia-resistant LA neurons while depressed in the ischemia-vulnerable MS 
neurons after ischemia. 
Mechanisms for the enhancement of evoked IPSCs in LA neurons after 
ischemia 
The enhancement of evoked IPSCs in LA neurons after ischemia could be due to 
the increased presynaptic GABA release, or the increased postsynaptic response 
to GABA.  To further determine the pre- and/or postsynaptic mechanisms, we 
performed paired-pulse tests, recorded spontaneous IPSCs, miniature IPSCs, 
and postsynaptic currents on exogenous GABA application.   
LA neurons exhibited paired-pulse depression, indicating a high initial 
release probability (Figure 15A).  Paired-pulse ratio (PPR) was 0.69±0.03 under 
the control condition (n=12), 0.50±0.05 at 3 h after ischemia (n=8; P<0.01), and 
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0.52±0.02 at 24 h after ischemia (n=10; P0.01; Figure 15B).  The decreased 
PPR suggests an increase of presynaptic release probability after ischemia.  
Spontaneous IPSCs compose of both the quanta-release events and the 
action potential-mediated events.  The frequency of spontaneous IPSCs was 
significantly increased after ischemia.  In the control, the frequency was 
1.24±0.15 Hz (n=17); at 3 h after ischemia, it was 2.01±0.3 Hz (n=12; P<0.05); at 
24 h after ischemia, it was 2.01±0.26 Hz (n=15; P0.05).  The amplitude of 
spontaneous IPSCs was slightly decreased, although this was not statistically 
significant.  In the control, it was 20.02±1.74 pA (n=17); at 3 h after ischemia, it 
was 16.99±1.27 pA (n=12; P>0.05); at 24 h after ischemia, it was 16.52±1.10 pA 
(n=15; P>0.05; Figure 16A-C).   
Miniature IPSCs represent only the random quantal release of 
neurotransmitters.  The frequency of miniature IPSCs showed no change after 
ischemia (control: 1.52±0.34 Hz, n=11; 3 h after ischemia: 1.03±0.17 Hz, n=10; 
P>0.05; 24 h after ischemia: 1.30±0.27 Hz, n=12; P>0.05).  The amplitude of 
miniature IPSCs was significantly decreased at 24 h after ischemia, indicating 
depressed postsynaptic responses (control: 15.08±0.67 pA, n=11; 3 h after 
ischemia: 14.35±0.94 pA, n=10; P>0.05 compared to the control; 24 h after 
ischemia: 12.16±0.5 pA, n=12; P<0.01 compared to the control; P<0.05 
compared to 3 h after ischemia; Figure 17A-C).   
To confirm that postsynaptic responses are depressed after ischemia, 
exogenous GABA application (300 μM) was used to examine the postsynaptic 
responses.  The current amplitude induced by exogenous GABA application was 
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reduced at 24 h after ischemia.  It was 566±84 pA in the control (n=5), 510±64 
pA at 3 h after ischemia (n=11; P>0.05 compared to the control), and 305±55 pA 
at 24 h after ischemia (n=6; P<0.05 compared to the control; P<0.05 compared to 
3 h after ischemia; Figure 18). 
An increase of presynaptic release probability could be concluded from 
the PPR study.  However, the frequency of miniature IPSCs did not change after 
ischemia, which does not support this conclusion.  The explanation for the 
increase in the frequency of spontaneous IPSCs is that the excitability of 
presynaptic terminals is significantly increased after ischemia, which results in an 
increase of presynaptic release.  Therefore, both pre- and postsynaptic 
mechanisms are involved in the alterations of inhibitory synaptic transmission 
after ischemia.  Presynaptically, the GABA release is increased.  Postsynaptically, 
the GABAA receptors show depressed responses at 24 h after ischemia.  But in 
all, the presynaptic effects far exceed the postsynaptic effects, which results in 
the facilitation of inhibitory synaptic transmission after ischemia (Table 2).  
Modulation of GABA release by presynaptic GABAA receptors in the control 
LA neurons 
Morphological studies have shown that LA neurons receive very few inhibitory 
inputs (Chang and Kita, 1992), which tells why the frequency of miniature and 
spontaneous IPSCs is very low as observed in this study and previous studies 
(Bennett and Wilson, 1999).   
To explore whether presynaptic GABAA receptors play a role in the 
modulation of inhibitory synaptic transmission, we recorded evoked IPSCs in the 
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control LA neurons before and after muscimol application.  It has been known 
that muscimol could activate GABAB receptors but at a higher EC50 of 25 μM 
(compared to the EC50 of 1 μM for GABAA receptors) (Yamauchi et al., 2000).  
Therefore, at a concentration of 1 μM used in the present study, muscimol should 
have only activated GABAA receptors.  Muscimol (1 μM) was applied for 5 min 
via bath perfusion.  Recordings were made after muscimol application.  Baseline 
noise and holding current were increased in the presence of muscimol, indicating 
the activation of postsynaptic GABAA receptors.  After muscimol application, the 
amplitude of evoked IPSCs (at 3T) was depressed by 64±10%.  Before muscimol 
application, the amplitude was 53±13 pA (n=7).  After muscimol application, the 
amplitude was 35±10 pA (n=7; P>0.05; Figure 19A1, B).  No significant change 
of PPR was detected after muscimol application (before: 0.69±0.04; after: 
0.74±0.12; 108±17% of the pre-application level, n=7; P>0.05; Figure 19A1, B). 
We also examined spontaneous IPSCs before and after muscimol 
application.  The frequency of spontaneous IPSCs was decreased (before: 
1.01±0.16 Hz; after: 0.71±0.12 Hz; 64±9% of the pre-application level, n=7; 
P<0.05) and the amplitude was increased (before: 16.48±1.80 pA; after: 
22.21±2.90 pA; 136±8% of the pre-application level, n=7; P<0.01; Figure 20) 
after muscimol application.   
From the data above, muscimol activates both pre- and postsynaptic 
GABAA receptors.  Presynaptically, muscimol decreases GABA release as 
inferred from the decrease in the frequency of spontaneous IPSCs.  
Postsynaptically, muscimol enhances GABAA-mediated currents as inferred from 
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the increase in the amplitude of spontaneous IPSCs.  Since muscimol has 
opposite effects on pre- and postsynaptic sites, no significant changes could be 
detected in the amplitude of evoked IPSCs and PPR.     
Modulation of GABA release by presynaptic GABAA receptors in LA 
neurons at 24 h after ischemia 
We also examined whether muscimol has the same effects on inhibitory synaptic 
transmission in LA neurons at 24 h after ischemia.  Muscimol significantly 
increased the amplitude of evoked IPSCs to 177±15% of the pre-application level.  
Before muscimol application, it was 95±34 pA.  After muscimol application, it was 
140±44 pA (n=8; P<0.01; Figure 19A2, B).  Paired-pulse tests showed that PPR 
decreased to 76±5% of the pre-application level.  Before muscimol application, it 
was 0.51±0.04.  After muscimol application, it was 0.40±0.03 (n=6; P<0.05; 
Figure 19A2, B).  
The frequency of spontaneous IPSCs was increased (before: 2.02±0.36 
Hz; after: 2.91±0.28 Hz; 148±14% of the pre-application level, n=6; P<0.05) and 
the amplitude showed no change (before: 16.43±2.33 pA; after: 17.21±1.68 pA; 
107±5% of the pre-application level, n=6; P>0.05; Figure 21) after muscimol 
application. 
Therefore, muscimol presynaptically increases GABA release after 
ischemia.  Muscimol differentially modulates presynaptic GABA release in the 
control and ischemic neurons.   
To reveal the role of calcium in muscimol’s facilitative effects on inhibitory 
synaptic transmission, spontaneous IPSCs were recorded before and after 
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muscimol application at 24 h after ischemia in the Ca2+-free solution.  Cadmium, 
which is a blocker of the voltage-gated calcium channels, was not used since 
cadmium itself is known to block GABAA responses (Fisher and Macdonald, 
1998).  Furthermore, it is reported that GABAA currents in LA neurons are zinc-
sensitive (Yan and Surmeier, 1997).  When the bathing solution was switched 
from the normal aCSF to the Ca2+-free aCSF, the amplitude (before: 16.89±1.03 
pA; after: 13.90±0.62 pA; 87±4% of the pre-Ca2+ removal, n=8; P<0.05) and 
frequency (before: 1.54±0.29 Hz; after: 0.89±0.19 Hz; 61±10% of the pre-Ca2+ 
removal, n=8; P<0.05; Figure 22A, B) of spontaneous IPSCs were greatly 
decreased.  In the Ca2+-free aCSF, muscimol application had no effect on the 
frequency (before: 0.94±0.20 Hz; after: 0.77±0.17 Hz; 87±12% of the pre-
application level, n=7; P=0.15) and amplitude (before: 13.18±0.90 pA; after: 
13.96± 0.76 pA; 113±7% of the pre-application level, n=7; P=0.25; Figure 22A, C, 
D) of spontaneous IPSCs after ischemia.  Therefore, muscimol’s facilitation on 
presynaptic GABA release after ischemia is sensitive to the extracellular calcium.  
Unlike spontaneous IPSCs, miniature IPSCs showed no significant 
changes in the frequency (before: 1.35±0.50 Hz; after: 1.27±0.56 Hz; 95±7% of 
the pre-application level, n=6; P>0.05) and amplitude (before: 13.01±1.01 pA; 
after: 13.91±1.22 pA; 111±4% of the pre-application level, n=6; P>0.05; Figure 
23) after muscimol application in the ischemic neurons.  Therefore, muscimol’s 
facilitation on presynaptic GABA release after ischemia is dependent on the 
voltage-gated sodium channels.   
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The above data indicates that activation of presynaptic GABAA receptors 
enhances presynaptic GABA release after ischemia, which is sensitive to both 
extracellular calcium and voltage-gated sodium channels.  Therefore, activation 
of presynaptic GABAA receptors on the GABAergic terminals results in differential 
effects in the postsynaptic LA neurons of control and after ischemia (Table 3).  
We make the following explanation.  In the control condition, intracellular chloride 
concentration is very low and the reversal potential for chloride is more negative 
than the resting membrane potential.  Therefore, following the activation of 
presynaptic GABAA receptors, there will be a chloride influx and membrane 
hyperpolarization in the presynaptic terminals.  After ischemia, intracellular 
chloride concentration is increased and the reversal potential for chloride is more 
positive than the resting membrane potential.  Following the activation of 
presynaptic GABAA receptors, there will be a chloride efflux and membrane 
depolarization in the presynaptic terminals, which will activate voltage-gated 
sodium channels and voltage-gated calcium channels.  Thus, presynaptic 
transmitter release is increased and a bigger postsynaptic response occurs in the 
postsynaptic LA neurons (Figure 24). 
GAD expression in the striatum before and after ischemia 
MS neurons provide inhibitory inputs to LA neurons (Bolam et al., 1986; Martone 
et al., 1992).  With the massive degeneration of MS neurons (especially in the 
dorsolateral striatum) after ischemia, how could the inhibitory synaptic 
transmission be enhanced in LA neurons?  To answer this question, we studied 
GAD in the striatum before and after ischemia. 
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There are two isoforms of GAD in the striatum, GAD65 and GAD67.  
GAD65 is abundant in the terminals of MS neurons whereas GAD67 is most 
abundant in the cell bodies of GABAergic interneurons (Mercugliano et al., 1992).  
Since LA neurons receive inhibitory inputs from MS neurons, we examined the 
immunoreactivity of GAD65 before and after ischemia.  GAD65-immunopositive 
terminals were observed in striatal sections after Avidin-Biotin Complex (ABC) 
reactions (Figure 25A).  The optical density of GAD65-positive terminals in the 
dorsolateral striatum showed a significant increase from 25.31±5.94 in control 
(n=6) to 69.01±2.79 in 1 day (n=6; P<0.05) and 69.36±14.21 in 3 days (n=6; 
P<0.05; Figure 25B) after ischemia.  There were no significant differences 
between 1 day and 3 days.   
We also did immunofluorescence labeling of GAD65 in the striatal 
sections.  The number, size, and optical density of GAD65-positive puncta were 
estimated in the dorsolateral region of the striatum by using the image analysis 
software, Image J (NIH).  After ischemic insult, the number of GAD65-positive 
puncta significantly increased (Figure 26A).  For the control group, the number 
was 554.27±109.26/field (200x150 µm; n=6).  1 day after ischemia, the number 
was 2077.17±341.5/field (n=6; P<0.05).  3 days after ischemia, the number was 
2494.94±294.81/field (n=6; P<0.05; Figure 26B).  There were no significant 
differences between 1 day and 3 days.  The average size of the GAD65-positive 
puncta showed no significant change (data not shown).  The optical density of 
the GAD65-positive puncta was significantly increased at 3 days after ischemia.  
53 
 
It was 60.41±1.75 in the control (n=6), 64.02±0.33 in one day (n=6; P>0.05), and 
69.97±3.74 in 3 days after ischemia (n=6; P<0.05; Figure 26C). 
The increased number of GAD65-positive puncta observed after ischemia 
could be an artifact due to the easy detection of high-density puncta after 
ischemia.  Therefore, the number of inhibitory synapses in the control is actually 
more than that after ischemia.  But the low optical density makes them not 
detectable in the control striatum.  Data from the miniature IPSCs recordings 
does not support the increase in the number of inhibitory synapses since the 
frequency didn’t change after ischemia.  The massive degeneration of MS 
neurons, the major GABAergic neuronal population in the striatum, does not 
support the increase in the number of inhibitory synapses after ischemia.  In 
addition, the increase in the threshold of the stimulus intensity indicates that 
there is a decreased availability of inhibitory terminals after ischemia.  The 
increase in the optical density of GAD65-positive puncta after ischemia indicates 
that there is an increase in the number of synapses that highly express GAD65.  
Because the striatum is mainly composed of MS neurons (Rymar et al., 
2004), ischemic injury results in a vast decrease of the striatal cellular population.  
This dramatic loss in density may suggest that the components remaining in the 
striatum are more readily accessible to antibodies.  The ischemic injury itself may 
also facilitate the penetration of the antibodies to the cells.  Therefore, the 
increased immunoreactivity of GAD65 might not result from postischemic 
molecular or intracellular changes but rather due to easier access to the 
antibodies.  To address this issue, we examined the immunoreactivity of vGLUT2 
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and GAD67 after ischemia.  If the increased immunoreactivity of GAD65 is due to 
increased access to antibodies, the immunoreactivity of vGLUT2 and GAD67 
might also increase after ischemia.  VGLUT2 is specially located on the 
glutamatergic terminals from the thalamus that form synapses on LA neurons in 
the striatum (Fremeau et al., 2001; Herzog et al., 2001; Lapper and Bolam, 1992).  
Our data suggests that there is no significant increase in the optical density of 
vGLUT2 immunoreactivity after ischemia (Figure 27A and B).  In fact, at three 
days after ischemia, there is decreased immunoreactivity of GAD67 in the 
dentate gyrus of the hippocampus compared to the control (Figure 28).  Our data 
suggests the increased penetration of antibodies does not contribute to the 
increased immunoreactivity of GAD65. 
To test if the increased immunoreactivity of GAD65 reflects the increased 
expression level of GAD65 after ischemia, we performed western blotting.  
Striatal sections were dissected out from the control rats, rats at 1 day and 3 
days after ischemia.  Equal amounts (20 μg) of protein were analyzed for GAD65 
expression level.  The relative density of the bands for GAD65 increased 
significantly after ischemia.  For the control group, it was 100±16.93% (n=4).  1 
day after ischemia, it was 289.86±37.85% (n=4; P<0.05).  3 days after ischemia, 
it was 284.86±61.70% (n=4; P<0.05; Figure 29).  There were no significant 
differences between 1 day and 3 days.   
Therefore, GAD65 expression is enhanced in the striatum confirmed by 
both immunohistochemical and western blotting analysis.  The increased 
expression of GAD65 highly suggests that presynaptic GABA synthesis is 
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enhanced after ischemia, which might contribute to the enhanced inhibitory 
synaptic transmission in LA neurons after ischemia.  
Muscimol’s effect on ischemic neuronal injury in the striatum 
We observed an enhancement of inhibitory synaptic transmission in ischemia-
resistant LA neurons and a depression of inhibitory synaptic transmission in 
ischemia-vulnerable MS neurons.  Muscimol enhanced inhibitory synaptic 
transmission in LA neurons by presynaptically increasing GABA release after 
ischemia.  To answer the question whether facilitation of inhibitory synaptic 
transmission could protect striatal neurons against ischemia, we treated rats with 
muscimol 30 min before ischemia and examined the ischemic neuronal injury by 
counting survived cells in the striatum.  Previous studies have shown that 
muscimol has neuroprotective effects against ischemia, which has been detailed 
in the introduction part (inhibitory synaptic transmission and postischemic 
neuronal injury).  However, most of the studies were performed in the 
hippocampus and very few in the striatum.   
Compared to the ischemic rats without muscimol treatment, the number of 
survived cells (defined as cells with normal morphology) in the striatum (both 
dorsolateral and dorsomedial parts) was significantly increased (Figure 30).  For 
the ischemia group, the number of survived cells was 85.12±14.67/field (400x300 
μm; n=6).  For the muscimol treatment group, the number was 
171.44±29.54/field (n=9, P<0.05).  This was mainly contributed by the increase in 
the survived cells in the dorsomedial striatum (ischemia group: 
101.18±15.30/field, n=6; muscimol treatment group: 224.22±36.78/field, n=9; 
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P<0.05).  The number of survived cells in the dorsolateral striatum showed no 
significant changes with muscimol treatment (ischemia group: 69.07±14.59/field, 
n=6; muscimol treatment group: 118.67±25.40/field, n=9; P=0.16; Figure 31).  
Although the difference is not statistically significant, the data suggests that there 
might be an increase.  Additional studies are needed to determine definitively 
whether or not there is a protective effect in the dorsolateral striatum. 
The significant increase in the survived cells was found in the dorsomedial 
striatum, suggesting that cells in the dorsomedial part are not severely damaged 
and are savable from ischemic injury.  This is consistent with previous studies, 
showing that ischemic damage is more severe in the dorsolateral striatum than 
that in the dorsomedial striatum (Pulsinelli et al., 1982).  We don’t know the 
identities of the survived cells after muscimol treatment by HE staining.  Besides 
LA neurons as indicated by the large size, we assume that most of them are MS 
neurons as indicated by their medium size.  Whether progenitor cells migrated 
from the SVZ contribute to the pool of the survived cells after muscimol treatment 
remains unclear. 
In all, our study demonstrated that inhibitory synaptic transmission was 
enhanced in ischemia-resistant LA neurons after transient cerebral ischemia.  
There are two mechanisms contributing to this enhancement.  One is that the 
activation of presynaptic GABAA receptors increased presynaptic GABA release 
after ischemia.  The other is the increased expression of GAD.  Facilitation of 
inhibitory synaptic transmission by muscimol significantly increased the number 
of survived cells in the striatum, especially in the dorsomedial striatum after 
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ischemia.  Therefore, the enhancement in inhibitory synaptic transmission might 
reduce excitotoxicity and contribute to the selective survival of LA neurons after 
ischemia.   
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DISCUSSION 
Mechanisms for the alterations of inhibitory synaptic transmission in LA 
neurons after ischemia 
The present study observed an increase of evoked IPSCs in LA neurons after 
ischemia.  Both pre- and postsynaptic mechanisms are involved in the alterations 
of inhibitory synaptic transmission based on the following findings.  1. PPR is 
depressed while the frequency of spontaneous IPSCs is increased after ischemia.  
2. The mean amplitude of miniature IPSCs and the currents induced by 
exogenous GABA application are depressed after ischemia.  Therefore, 
presynaptically, the GABA release is increased.  Postsynaptically, the GABAA 
receptors show depressed responses at 24 h after ischemia (Table 2).   
We found that the activation of presynaptic GABAA receptors by muscimol 
decreased presynaptic GABA release onto the control LA neurons while 
facilitated GABA release onto LA neurons after ischemia based on the following 
observations.  1. The frequency of spontaneous IPSCs was decreased while the 
amplitude was increased in the control LA neurons after muscimol application.  
The opposite effects on the frequency and amplitude also helped explain why 
there was no significant change in the amplitude of evoked IPSCs and PPR.  2. 
The amplitude of evoked IPSCs was increased and PPR was depressed in LA 
neurons after muscimol application at 24 h after ischemia.  3. The frequency of 
spontaneous IPSCs was increased in LA neurons after muscimol application at 
24 h after ischemia.  Muscimol’s facilitative effect after ischemia was dependent 
on extracellular calcium and voltage-gated sodium channels (Table 3).   
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Upon the vesicle release, the size of postsynaptic currents is determined 
by quantal size (q), the readily releasable pool (RRP) of vesicles (N), and the 
probability of each vesicle being released (pr) (Johnson and Wernig, 1971; 
Quastel, 1997; Zucker, 1973).  The quantal size is decreased since the mean 
amplitude of miniature IPSCs was depressed after ischemia.  There are three 
ways to determine the size of RRP.  One is by delivering a train of action 
potentials (Rosenmund and Stevens, 1996).  The second is by step-like 
depolarization (Schneggenburger et al., 2002).  The third is by using hypertonic 
sucrose solution, which is only applicable to cultured neurons (Rosenmund and 
Stevens, 1996).  However, most of the studies used hippocampal slices, cell 
cultures, or calyx of Held to determine the size of RRP.  Whether these methods 
are applicable to striatal slices or not is still unknown.  As to the presynaptic 
release probability, data from paired-pulse stimulation highly suggests the 
increase of presynaptic release probability after ischemia.  However, no change 
was found in the frequency of miniature IPSCs confounding this situation (Table 
1).  There are two possibilities for this.  One is that the presynaptic release 
probability is really increased but the postsynaptic receptors failed to detect them 
due to the decrease of the quantal size.  The other is that presynaptic release is 
increased, which is action-potential dependent, due to the increase in the 
frequency of spontaneous IPSCs.  The latter possibility seems more probable 
since the data from muscimol application also supports this.  A possible 
explanation for this is that the excitability of the functional terminals might have 
increased after ischemia.  The increase of presynaptic release probability as 
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inferred from the paired-pulse tests might be dependent on the increased 
excitability of the presynaptic terminals.   
Previous studies suggest that presynaptic mechanisms contribute to the 
abnormal synaptic transmission after ischemia.  For example, MS neurons show 
decreased inhibitory synaptic transmission and LA neurons show decreased 
excitatory synaptic transmission after ischemia due to the activation of 
presynaptic adenosine A1 receptors (Centonze et al., 2001b; Pang et al., 2002); 
MS neurons show increased excitatory synaptic transmission after ischemia due 
to the activation of presynaptic ATP P2X receptors (Zhang et al., 2006).   
The number and the function of postsynaptic receptors are the main 
determinants of quantal size.  Normally, in the central nervous system, the 
presynaptic vesicles could saturate postsynaptic receptors, the number of 
postsynaptic receptors is very important in determining the quantal size.  
However, if the presynaptic vesicles could not saturate postsynaptic receptors, 
the presynaptic release kinetics and the neurotransmitter amount in the vesicles 
are important determinants of quantal size.  Therefore, presynaptic factors could 
also participate in the modulation of quantal size (Atwood and Karunanithi, 2002; 
Liu, 2003). 
Decreased number and/or depressed functions of postsynaptic GABAA 
receptors might contribute to the depressed postsynaptic responses as observed 
from the exogenous GABA application and miniature IPSCs recording.  Whether 
the number of postsynaptic GABAA receptors is changed after ischemia remains 
unclear.  The functions of postsynaptic GABAA receptors might have depressed 
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since GABAA responses are very sensitive to intracellular ATP levels (Shirasaki 
et al., 1992).  Decreased ATP production after ischemia induces a selective and 
rapid rundown of the postsynaptic GABAA responses (Harata et al., 1997).  Other 
factors induced by ischemia, like calcium overload and the production of 
arachidonic acids, also depress GABAA receptor function (Schwartz et al., 1992).   
The main GABAA receptor subunits in the rat striatum are α1, β2/3, and γ2.  
β2/3 subunits were commonly found on MS neurons and GABAergic 
interneurons (Fujiyama et al., 2000).  In MS neurons, the expression of α5 and 
β3 subunits is responsible for the tonic conductances (Ade et al., 2008; Janssen 
et al., 2009).  Studies from Yan et al. observed that nearly all LA neurons co 
express α2, α4, β1, and γ2 mRNAs (Yan and Surmeier, 1997).  Whether 
ischemia could modulate these subunits in the striatum is still unknown. 
As to muscimol’s facilitative effect after ischemia, we speculated that the 
chloride concentration in the presynaptic terminals was increased after ischemia, 
which induced a depolarized reversal potential of chloride.  Excitatory effects 
occurred if the depolarization overcomes the shunting effects while at the same 
time, the inactivation of sodium and calcium channels not yet happen.  Since we 
speculated that the intraterminal chloride concentration was increased after 
ischemia, it is very natural to ask the question: is the chloride concentration in LA 
neurons also increased after ischemia?  We could not answer this question since 
we used whole-cell patch-clamp recording in this study.  However, even if 
chloride concentration is increased in LA neurons after ischemia, LA neuron cell 
bodies have lower susceptibility to the disruption of ionic imbalance than MS 
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neurons since their smaller surface-to-volume ratio.  What that means is that LA 
neurons might have a slower and smaller shift in the reversal potential of chloride 
compared to that of the MS neurons.  And they are less likely to convert from 
inhibitory to excitatory upon the GABAA receptor activation.  One example from 
previous studies is that in CA3 region, the activity-driven shift in the chloride 
reversal potential is much faster and larger in the interneurons than in the 
pyramidal cells.  Besides the different surface-to-volume ratio, they also 
mentioned other factors involved.  These two types of neurons might have 
different expressions of chloride transportation systems or be in different 
phosphorylation cascades that control the transporters.  The transportation 
systems in pyramidal neurons might be more efficient in extruding the chloride 
out of the cell.  They might have different carbonic anhydrase activity and 
different availability to HCO3-.  The interneurons might have more access to 
HCO3- and the GABAA receptors on interneurons have high permeability to 
HCO3- (Lamsa and Taira, 2003).   
Inhibitory synaptic transmission and postischemic neuronal injury 
Large accumulation of GABA in the extracellular space has been demonstrated 
by in vivo and in vitro studies during ischemia and early after reperfusion (Allen et 
al., 2004; Globus et al., 1988).  But as to the alterations of GABAergic synaptic 
transmission, different neurons show different changes.  Inhibitory synaptic 
transmission is depressed or disappeared in striatal MS neurons during ischemia 
and early after reperfusion in vivo (Gajendiran et al., 2001; Xu, 1995).  The 
frequency of spontaneous IPSCs is increased in neocortical layer 5 neurons and 
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hippocampal CA1 neurons during simulated ischemia in vitro (Allen and Attwell, 
2004; Fleidervish et al., 2001).  In the present study, we observed an 
enhancement of inhibitory synaptic transmission in the ischemia-resistant LA 
neurons at 3 h and 24 h after transient cerebral ischemia while a depression in 
inhibitory synaptic transmission in ischemia-vulnerable MS neurons at 8 h after 
transient cerebral ischemia.   
The enhancement of inhibitory synaptic transmission in the ischemia-
resistant LA neurons might contribute to the decrease of excitotoxicity by 
depressing the overall excitability.  This is consistent with previous studies 
showing that LA neurons have decreased excitatory synaptic transmission (Pang 
et al., 2002) and excitability after ischemia (Deng et al., 2008).  On the contrary, 
ischemia-vulnerable MS neurons show increased excitatory synaptic 
transmission (Zhang et al., 2006) and depressed inhibitory synaptic transmission 
after ischemia.  The balance between excitation and inhibition is needed to 
maintain the normal brain function.  Depressed excitability would limit calcium 
influx and stop the cascades to postischemic neuronal death.  The differential 
changes of the synaptic transmission in LA neurons and MS neurons might 
contribute to their differential vulnerability to ischemia.  In the hippocampus, CA1 
pyramidal neurons survive (Pulsinelli et al., 1982) transient cerebral ischemia 
while CA1 interneurons die (Schlander et al., 1988).  They also show differential 
changes in inhibitory synaptic transmission after transient cerebral ischemia.  
CA1 pyramidal neurons exhibit depressed responses to GABA while CA1 
interneurons not (Zhan et al., 2006).  
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In the present study, the application of muscimol at 30 min before the 
ischemic insults significantly increased the number of survived cells in the 
striatum.  This is consistent with previous studies showing that muscimol is 
neuroprotective against ischemia, as detailed in the introduction part (inhibitory 
synaptic transmission and postischemic injury).  However, considering the 
neuronal swelling as the consequence of chloride influx during ischemia 
(Inglefield and Schwartz-Bloom, 1998a, b), the neuroprotective effects by 
facilitating inhibitory synaptic transmission is not that convincing.  In fact, there 
are studies demonstrating that chloride influx either through GABAA receptors or 
other chloride channels are not neuroprotective against excitotoxic injury.  Van 
Damme et al. observed that AMPA application to motoneurons results in chloride 
influx through the activation of chloride channels, which exacerbates excitotoxic 
death by increasing AMPA receptor conductance and enhancing the driving force 
of calcium through repolarization.  Co-application of GABA and AMPA enhances 
chloride influx and excitotoxic cell death (Van Damme et al., 2003).        
Application of GABA or activation of GABA receptors does not show 
neuroprotection in cultured neurons, while blockade of GABAA receptors 
alleviates cell death (Erdo et al., 1991; Erdo and Michler, 1990; Koh and Choi, 
1987).  Different experimental preparations might explain the different effects of 
GABAA receptor activation and chloride influx.  One other possible explanation is 
that during or after excitotoxic insults, the intracellular chloride concentration 
might have increased to the extent that further potentiation of GABA activity 
results in excitatory effects, due to the more depolarized chloride reversal 
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potential relative to the resting membrane potential.   Under this condition, the 
activation of GABAA receptors may not be neuroprotective.  Therefore, the extent 
of GABAA receptor activation should be delicately controlled to obtain 
neuroprotection. 
Slow synaptic inhibition mediated by GABAB receptors is also a concern 
for neuroprotection.  It has been revealed that increasing GABAB receptor 
function will help to reduce excitotoxicity and promote neuronal survival after 
ischemia (Costa et al., 2004; Dave et al., 2005; Jackson-Friedman et al., 1997; 
Kulinskii and Mikhel'son, 2000; Kuramoto et al., 2007).  Studies from Kuramoto et 
al. showed that GABAB receptors are phosphorylated by 5’AMP-dependent 
protein kinase (AMPK), which is activated under ischemia, and results in 
neuronal survival (Kuramoto et al., 2007).  Considering the activation of 
presynaptic GABAB autoreceptors, the release of glutamate, GABA, and a group 
of other neurotransmitters will be decreased.  From one point of view, this is 
neuroprotective under ischemic injury since synaptic activity will be decreased, 
energy will be conserved, and neuronal exposure to excitotoxicity will be limited.  
From the other point of view, varying effects might occur if the release of a group 
of neurotransmitters is decreased, which makes the situation more complicated 
to explain.   
Functional significance and limitations of the present study 
We demonstrated an enhancement of inhibitory synaptic transmission in 
ischemia-resistant LA neurons after transient cerebral ischemia.  Muscimol 
application at 30 min before the ischemic insults significantly improves the 
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number of survived cells in the striatum compared to the non-treatment group.  
Our data strongly suggests that facilitation of inhibitory synaptic transmission 
protects striatal neurons against cerebral ischemia.  This is corroborated by the 
previous studies from Zhang’ s group, which showed that muscimol application 
protects hippocampal CA1 pyramidal neurons against transient cerebral ischemia 
(Han et al., 2008; Xiao et al., 2007; Xu et al., 2008; Zhang et al., 2007; Zhou et 
al., 2008). 
One of the mechanisms for the enhancement of inhibitory synaptic 
transmission in LA neurons after ischemia is that presynaptic GABAA receptors 
help increase GABA release.  Large accumulation of GABA in the extracellular 
space has been demonstrated by in vivo and in vitro studies during ischemia and 
early after reperfusion (Allen et al., 2004; Globus et al., 1988).  It is known that 
GABA release is initially by exocytosis and later by reversed uptake through 
GABA transporters (Allen et al., 2004).  The initial exocytosis is due to the 
depolarization by the rundown of Na+-K+-ATPase.  The activation of presynaptic 
GABAA receptors increases the chloride concentration in the presynaptic 
terminals.  GABA release happens when chloride reversal potential is positive 
than the resting membrane potential.  Based on this study, the large 
accumulation of GABA might be, at least in part, due to the activation of 
presynaptic GABAA receptors located on the GABAergic terminals.  In addition, 
GABAB receptors are activated under ischemic injury (Kuramoto et al., 2007), 
which results in depressed synaptic activity.  Whether GABA release will be 
facilitated or depressed is determined by the interplay among the extent of 
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energy rundown, presynaptic GABAA receptors (inhibitory or excitatory), and 
presynaptic GABAB receptors.  This also explains why GABA and glutamate 
accumulation only occurs during ischemia and early after reperfusion but not long 
lasting.  Thus, the present study provides a new way to explain the relationship 
among GABA, GABAA or GABAB receptors, and GABAergic synaptic 
transmission after ischemia.   
The present study could not directly demonstrate that the facilitation of 
inhibitory synaptic transmission will reduce excitotoxicity and thus protect LA 
neurons, considering excitotoxicity is the major mechanism for postischemic 
neuronal death.  Since LA neurons survive ischemia, they must have undergone 
little or no excitotoxicity.  Previous studies from this group showed that LA 
neurons have depressed excitatory synaptic transmission (Pang et al., 2002) and 
depressed excitability (Deng et al., 2008) after ischemia.  But we could not equal 
the depressed excitability to the depressed excitotoxicity.  Whether facilitation of 
inhibitory synaptic transmission in LA neurons is directly linked to depressed 
excitotoxicity or by some other mechanisms still needs further investigation.   
We demonstrated that the facilitation of inhibitory synaptic transmission by 
muscimol protects striatal neurons against ischemic insults.  However, we could 
not prove the causal link between facilitation of inhibitory synaptic transmission 
and the selective survival of LA neurons after ischemia.  The causal link is 
confirmative if LA neurons degenerate when the enhancement of inhibitory 
synaptic transmission in LA neurons is selectively blocked.  However, it seems 
not feasible to only block synaptic transmission in LA neurons.  Systemic or local 
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drug application of the GABAA receptor antagonist, like bicuculline, will affect a 
group of neurons and predispose them to epileptic activities, which will 
complicate the ischemia model.  
Although we did not perform behavioral tests in this study, we observed 
that most of the rats displayed hunched back, hypomobility, twitches and tremors 
in 24 h after transient cerebral ischemia.  Some of the rats showed body rotation.   
Since rats were sacrificed within 72 h, we could not examine long lasting 
neurological deficits (unpublished observations).  In fact, muscimol’s 
neuroprotective effects could be further corroborated by functional studies.  
Previous studies showed that sensorimotor dysfunctions occur mainly in 24-48 h 
after transient cerebral ischemia but no longer after that (Combs and D'Alecy, 
1987; Gionet et al., 1991).  If muscimol could improve the sensorimotor functions 
after ischemia, we would expect to see the ischemic rats with muscimol 
treatment show improvement in the tests of equilibrium and muscle strength, 
which are severely damaged in the rats in 24 h after global ischemia (Combs and 
D'Alecy, 1987; Gionet et al., 1991).  
We used spontaneous IPSCs recordings to reveal the mechanisms for the 
enhancement of evoked IPSCs in LA neurons after ischemia.  By doing so, we 
assumed that the vesicles fused spontaneously are from the same pool as the 
vesicles fused during stimulation.  We also assumed that the release dynamics 
are the same for spontaneous release and stimulation-induced release.  The last 
assumption we made was that spontaneous and stimulation-induced release 
activate the same postsynaptic structures.  However, these assumptions are 
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greatly challenged by the recent progress made in neurotransmitter release.  It is 
controversial whether the spontaneous release and evoked release are from the 
same pool.  Research from Kavalali’s group demonstrated that spontaneously 
endocytosed vesicles populate a reluctant/reserve pool that has little crosstalk 
with the activity-dependent pool in hippocampal synapses (Sara et al., 2005).  
Studies from other groups demonstrated that these two kinds of release are from 
the same pool (Groemer and Klingauf, 2007; Prange and Murphy, 1999).  If 
these two kinds of release are from different pools, it is highly possible that the 
release dynamics are also different.  Moreover, spontaneous release and evoked 
release activate different protein synthesis in the dendrites (Sutton et al., 2007; 
Sutton et al., 2004) thus differently affecting postsynaptic functions.  It is reported 
that spontaneous and evoked glutamate release activates two populations of 
NMDA receptors with limited overlap (Atasoy et al., 2008).  If these differences 
also existed in the GABAergic synaptic transmission in the striatum, it would be 
useless to explain the mechanisms for the enhancement of inhibitory synaptic 
transmission in LA neurons after ischemia by using the data from spontaneous 
and miniature IPSCs recording.  Therefore, we should be cautious when 
explaining the data.  
We observed an increased expression of GAD65 in the striatum by both 
immunohistochemical and western blotting analysis.  We concluded that there is 
an increase in the number of synapses that highly express GAD65.  As to the 
origin of this increased expression of GAD65, there are several possibilities.  One 
is that it is originated from the terminals of the survived MS neurons or the MS 
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neurons that are not severely damaged (especially the ones in the dorsomedial 
striatum).  Studies from Pulsinelli et al. systematically estimated the effect of 
duration of ischemia on the severity of ischemic neuronal damage.  They found 
that twenty-minute of transient forebrain ischemia will induce neuronal damage in 
50% of the striatal populations after 72 h of survival (Pulsinelli et al., 1982).  The 
remaining 50% of the striatal neurons are still functional.  Considering the 
majority of striatal neurons are MS neurons (97.7%) in the striatum (Rymar et al., 
2004), most of the functional neurons after ischemia should be MS neurons 
(especially the ones in the dorsomedial striatum) (Pulsinelli et al., 1982), which 
might contribute to the increased expression of GAD65.  The other possibility is 
that the survived GABAergic interneurons (GAD67 positive) might express 
GAD65 after ischemia and this should be confirmed by further investigations.   
Since GAD65 is the key enzyme for the production of GABA, we 
speculated that presynaptic synthesis of GABA was increased and contributed to 
the increase of presynaptic GABA release.  GAD67 is also a key enzyme for the 
synthesis of GABA.  However, we focus on the expression of GAD65 due to the 
following difference between GAD65 and GAD67.  GABA synthesized by GAD65 
is mainly found in phasically active neurons and more likely to be involved in 
synaptic transmission.  GABA synthesized by GAD67 is mainly found in the 
tonically active neurons and mostly provides a pool of GABA for general 
metabolic activity (Martin and Rimvall, 1993).  However, the increased 
expression of GAD65 does not mean increased function.  Or the increased 
expression is just to compensate for an actually depressed function of GAD65.  
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We don’t know whether this increased expression of GAD65 in the striatum is 
transient or permanent since we only examined GAD65 expression in the rats at 
1 day and 3 days after ischemia. 
Future studies 
During this study, we encountered many interesting questions.  If possible, I 
would pursue the following projects.  
1. The inhibitory inputs from GABAergic interneurons to LA neurons.  
Are there any inhibitory inputs from GABAergic interneurons to LA neurons?  
This has long been doubted though not substantiated yet (Bennett and Wilson, 
1998; Koos and Tepper, 1999).  GABAergic interneurons provide strong 
inhibitory inputs to MS neurons, which is demonstrated by both morphological 
(Bennett and Bolam, 1994; Kita et al., 1990) and electrophysiological studies 
(Koos and Tepper, 1999; Koos et al., 2004).  However, there are almost no 
corresponding reports showing that GABAergic interneurons provide inhibitory 
inputs to LA neurons.  Consistently, electron microscopic (EM) studies found that 
the somata and dendrites of LA neurons are poorly innervated by inhibitory 
terminals (Chang and Kita, 1992).  Among the three types of GABAergic 
interneurons, the synaptic contacts from PV-containing GABAergic interneurons 
to LA neurons are not found although the contacts from LA neurons to 
GABAergic interneurons are frequently seen (Chang HT and Kita H, 1992).  
Reciprocal synaptic contacts are found between neuropeptide Y-containing 
GABAergic interneurons and LA neurons (Vuillet et al., 1992).  The synaptic 
connections between calretinin-containing GABAergic interneurons and LA 
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neurons are not reported.  Therefore, neuropeptide Y-containing GABAergic 
interneurons are the candidates providing inhibitory inputs to LA neurons.  The 
scarcity of LA neurons and GABAergic interneurons (2-3% of striatal population) 
makes it extremely difficult to catch their electrical connections.  One recent 
study speculates that the polysynaptic inhibitions from GABAergic interneurons 
to LA neurons are mediated by neuropeptide Y-containing GABAergic 
interneurons (Sullivan et al., 2008).   
The present study highly suggests that GABAergic interneurons provide 
inhibitory inputs to LA neurons.  Inhibitory synaptic transmission in LA neurons is 
enhanced at 24 h after transient cerebral ischemia, a time point at which MS 
neurons are severely damaged while GABAergic interneurons have survived.  
We speculated that the inhibitory inputs to LA neurons come from the survived 
GABAergic interneurons after ischemia.  Considering the small inhibitory inputs 
to LA neurons under control condition (Bennett and Wilson, 1999; Chang and 
Kita, 1992), there are two possibilities.  One is that the inhibitory contacts from 
GABAergic interneurons to LA neurons exist in the control condition but the 
terminals from GABAergic interneurons are functionally silent or masked by the 
overwhelming majority of the terminals from MS neurons.  However, they are 
functional and unmasked after ischemia.  Presynaptically silent synapses have 
been reported in a variety of brain structures and presynaptic unsilencing is very 
important for the expression of LTP (Atasoy and Kavalali, 2006).  Some of the 
molecular mechanisms implicated in the ischemia-induced neuropathology are 
also involved in the expression of long-term synaptic plasticity (Di Filippo et al., 
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2008).  These common mechanisms might contribute to the presynaptic 
unsilencing after ischemia and the expression of postischemic LTP.  The other 
possibility is that GABAergic interneurons establish inhibitory inputs onto LA 
neurons after ischemia as a result of synaptic reorganization. 
To answer these questions, paired recordings of GABAergic interneurons 
and LA neurons are necessary.  EM studies are also necessary to provide 
morphological evidence.  
2. Presynaptic GABAA receptors in the striatum.  The present study 
demonstrated that presynaptic GABAA receptors increase presynaptic GABA 
release after ischemia, which is sensitive to the extracellular calcium and voltage-
gated sodium channels.  This is concluded from electrophysiological data, for 
example, the PPR and the frequency of spontaneous IPSCs.  Whether these 
receptors are located on the presynaptic terminals where GABA is released or 
not is unclear.  It is known that synaptic activities in the dendrite and soma could 
control the generation of action potentials and the synaptic transmission that 
these action potentials initiate (Shu et al., 2006).  Therefore, we speculated that 
the exact location of the presynaptic GABAA receptors could be the presynaptic 
terminal, soma, or even the dendrites.  However, morphological studies, like 
post-embedding techniques, could not unequivocally localize the GABAA 
receptors to the pre- or postsynaptic structures due to the distortion between the 
membrane from the whole thickness of the section and the most superficial layer 
of the membrane available for the antibody (Fujiyama et al., 2000). 
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We found that muscimol’s effect on neurotransmitter release is inhibitory 
in control but facilitative after ischemia.  It is speculated that this is due to the 
increase of intraterminal chloride concentration after ischemia, which results in a 
more depolarized reversal potential of chloride.  To confirm this speculation, it is 
necessary to measure chloride concentration in the presynaptic terminals.  One 
way is to perform perforated-patch recording, in which intracellular chloride 
concentration could be derived from its reversal potential.  The other way is to 
use chloride indicator to get an estimate of chloride concentration from the optical 
signals.  However, both methods could only estimate the chloride concentration 
in cell bodies due to the fine structures of axons (except the calyx of Held).  The 
chloride concentration in the terminals might be different from that of the soma.  
In the mammalian central nervous system, the calyx of Held has a higher 
chloride concentration than that in the soma as demonstrated by perforated-
patch recording (Price and Trussell, 2006; Turecek and Trussell, 2001).  
Therefore, it would be a great challenge to confirm both the location of 
presynaptic GABAA receptors and the chloride concentration in presynaptic 
terminals. 
3. The electrophysiological properties of GABAergic interneurons after 
ischemia.  GABAergic interneurons provide feedforward inhibition in the striatum 
via their strong inhibitory inputs onto MS neurons.  The excitability of GABAergic 
interneurons greatly affects not only the inhibitory outputs from the striatum but 
also the inhibitory microcircuits in the striatum.  Studies from striatal slices show 
that fast-spiking GABAergic interneurons have relatively negative resting 
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membrane potential (-80 mV) and low input resistance (less than 140 MΩ).  They 
could fire action potentials only upon strong and constant depolarization.  But 
they could be synchronized to fire action potentials since they are connected to 
each other by gap junctions.  LTS GABAergic interneurons have depolarized 
resting membrane potential (-50 to -60 mV) close to action potential threshold 
and very high input resistance (greater than 500 MΩ) (Kawaguchi, 1993).  
However, whether their electrophysiological characters would change after 
ischemia remains unknown.   
The present study found that muscimol, by bath application, activates 
presynaptic GABAA receptors and increases GABA release after ischemia, which 
is dependent on the extracellular calcium and voltage-gated sodium channels.  
However, we could not exclude the possibility that inhibitory network properties in 
the striatum are changed or they are modified by muscimol after ischemia, 
leading to the phenomena we observed.  Since most of the GABAergic 
interneurons survive ischemic insults (Chesselet et al., 1990; Pulsinelli et al., 
1982), any changes in the excitability of these neurons, would significantly 
change the inhibitory network properties in the striatum after ischemia.   Other 
studies found that chronic dopamine deprivation could change firing properties in 
a subgroup of striatal GABAergic interneurons, thus change the IPSCs in MS 
neurons (Dehorter et al., 2009).  The main obstacle to study GABAergic 
interneurons after ischemia is the scarcity of these neurons in the striatum.  The 
identification of these neurons could be benefited from neurobiotin staining after 
successful recordings.    
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Overall summary 
This study demonstrated that inhibitory synaptic transmission was enhanced in 
ischemia-resistant LA neurons at 3 h and 24 h after ischemia while depressed in 
ischemia-vulnerable MS neurons at 8 h after ischemia.  The enhancement 
observed in LA neurons was due to the increased presynaptic GABA release.  
There are two mechanisms contributing to the increased GABA release.  One is 
that the activation of presynaptic GABAA receptors increased presynaptic GABA 
release after ischemia.  The other is the enhanced expression of GAD.  
Facilitation of inhibitory synaptic transmission by muscimol protected striatal 
neurons against ischemic insults.  Therefore, the enhancement in inhibitory 
synaptic transmission might reduce excitotoxicity and contribute to the selective 
survival of LA neurons after ischemia.   
77 
 
TABLES 
  
Percentage  
 
Immunohistochemical 
characters 
 
Firing properties 
 
MS neurons 
(GABAergic) 
 
97.7% 
 
GAD65, Calbindin, 
DARPP-32, Substance 
P, Dynorphin, 
Enkephalin 
 
Up and down states 
 
GABAergic 
interneurons 
 
2% 
 
1.PV, GAD67 
2.NPY, SOM, NOS 
3.Calretinin, GAD67 
 
1.Fast-spiking 
2.Low-threshold spike 
3.Unknown 
 
LA  
(cholinergic) 
interneurons 
 
0.3% 
 
CHAT, 
Acetylcholinesterase 
 
Broad action potentials, 
large-amplitude and 
long-duration 
afterhyperpolarizations 
 
Dopaminergic 
neurons 
 
Very few 
 
TH, DAT 
 
Unknown 
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Table 1 A table summarizes the percentage, immunohistochemical characters, 
and firing properties for each type of the striatal neurons.  
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PPR 
  
Presynaptic release probability 
 
Spontaneous IPSCs 
 
Frequency 
 
Presynaptic release 
 
Miniature IPSCs 
 
Mean Amplitude 
 
Postsynaptic response 
Currents induced by 
exogenous GABA 
  
Postsynaptic response 
 
Table 2 Both pre- and postsynaptic mechanisms are involved in the alteration of 
inhibitory synaptic transmission in LA neurons after ischemia.  Presynaptically, 
GABA release is increased as indicated from PPR and spontaneous IPSCs.  
Postsynaptically, GABAA receptors show depressed responses at 24 h after 
ischemia as indicated from miniature IPSCs and currents induced by exogenous 
GABA application.  But in all, the presynaptic effects far exceed the postsynaptic 
effects, which results in the facilitation of inhibitory synaptic transmission after 
ischemia.  
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Control 
 
Ischemia 
 
evoked IPSCs 
 
No change 
 
 
 
PPR 
 
No change 
 
 
 
Spontaneous IPSCs 
 
Frequency 
Amplitude 
 
Frequency 
Ca2+ & TTX-sensitive 
 
Conclusion 
 
Presynaptic release 
 
Presynaptic release 
 
Table 3 Muscimol application results in differential effects in control LA neurons 
and LA neurons after ischemia.  It decreases presynaptic GABA release in 
control while facilitates presynaptic GABA release after ischemia.   
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FIGURES 
 
 
Figure 1 Postischemic neuronal death and excitotoxicity.  Excessive glutamate 
release during ischemia could excite a neuron to death. 
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Figure 2 Functional connections of the basal ganglia with the cortex and other 
brain structures.  In the basal ganglia, striatum is the major input nucleus.  The 
internal segment of globus pallidus and the substantia nigra pars reticulate (p.r.) 
are the two major output nuclei.  The information flowed through the striatum 
finally goes back to the thalamus and cerebral cortex, where the striatum 
originally receive the inputs from.  P.c. represents substantia nigra pars 
compacta.  Red arrows indicate glutamatergic terminals; green arrows indicate 
inhibitory terminals; blue arrows indicate dopaminergic terminals. 
83 
 
 
 
 
Figure 3 The schematic drawing of the microcircuits in the striatum.  MS neurons 
provide inhibitory inputs to LA neurons and other MS neurons.  GABAergic 
interneurons provide strong inhibitory inputs to MS neurons.  LA neurons provide 
cholinergic inputs to MS neurons and GABAergic interneurons.  The percentage 
for each type of neuron in the striatal population is represented in the brackets.  
Crossed straight lines represent spiny dendrites; straight lines represent aspiny 
dendrites; curved lines represent axons.  Green represents GABAergic soma or 
axons; blue represents cholinergic soma or axons. 
84 
 
 
 
Figure 4 The schematic drawing (modified from Neuroanatomy, fifth edition, by 
Haines DE) of four-vessel occlusion model used in this project.  Two vertebral 
arteries were electrocauterized (represented by the black crosses) at the C1 level 
and the two common carotid arteries were occluded (represented by the blue 
lasso) with the tubing.    
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Figure 5 Sample traces of DC potential, blood pressure (BP), and cerebral blood 
flow (CBF) recording during the occlusion of carotid arteries and reperfusion.  DC 
potential was zeroed before occlusion.  After occlusion, it took about 2 min for the 
DC potential to reach -20 mV.  BP immediately increased while CBF decreased 
after occlusion.  The occlusion lasted 20 min, after which DC potential and BP 
returned to the pre-occlusion value in around 2 min. 
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Figure 6 Representative image showing the intrastriatal stimulation used in this 
study.  Stimulating electrode was placed 150-200 μm subjacent to the recording 
electrode.
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Figure 7 Striatal cells show morphological changes after transient cerebral 
ischemia.  (A) HE staining of the striatal slice (50 μm) from the control rats.  LA 
neurons were recognized by the large soma size among the other medium-sized 
neurons.  (B) HE staining of the striatal slice from the rats at 3 h after ischemia.  
Most of the neurons remained normal morphology.  HE staining of striatal slices 
from the rats at 24 h (C) and 72 h (D) after ischemia.  Most of the striatal cells 
exhibited pyknotic, shrunken nuclei while LA neurons remained morphologically 
normal (arrows).  Scale bar, 25 μm.   
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Figure 8 Photograph of one LA neuron intracellularly stained with neurobiotin 
showing few spines on the dendrites.  The longest diameter is around 50 μm for 
this neuron.  Scale bar represents 40 μm. 
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Figure 9 Photograph of one MS neuron intracellularly stained with neurobiotin 
showing spines on the dendrites.  The diameter is around 15 μm for this neuron. 
Scale bar represents 20 μm. 
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Figure 10 Identification of LA neurons.  (A) An infrared-DIC image of the striatal 
slice showing one LA neuron (arrow) and one adjacent medium-sized neuron.  
Scale bar represents 25 μm.  (B) Characteristic responses of one LA neuron to 
hyperpolarizing and depolarizing current pulses under the current-clamp 
recording.  Prominent afterhyperpolarizations after evoked action potentials and 
the depolarizing sag (arrow) upon hyperpolarizing pulses could be observed.  (C) 
Representative traces of evoked postsynaptic currents (ePSCs), currents 
recorded after the application of APV+CNQX, APV+CNQX+bicuculline, 
respectively.
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Figure 11 The I-V curves for LA neurons before and after ischemia.  The I-V 
curves showed that the reversal potential of evoked IPSCs was not changed at 
24 h after ischemia, indicating that the intracellular chloride concentration in LA 
neurons was not significantly changed at 24 h after ischemia. 
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Figure 12 Inhibitory synaptic transmission is enhanced in LA neurons after 
transient cerebral ischemia.  (A) Representative traces of evoked IPSCs (1T-5T) 
in LA neurons of the control and at 3 h, 24 h after ischemia.  All the traces are 
averages of 8 consecutive recordings.  (B) Grouped data (1T-5T) reveal that the 
amplitude of evoked IPSCs in LA neurons was significantly facilitated at 3 h and 
24 h after ischemia.  The values of the plotting are mean±SEM.  Asterisks 
indicate the significant changes compared to the control ones if not specified.  
*P< 0.05, ** P< 0.01.  These definitions of * and ** apply to all subsequent 
figures.   
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Figure 13 Inhibitory synaptic transmission is depressed in MS neurons after 
transient cerebral ischemia.  (A) Representative traces of evoked IPSCs (1T-4T) 
in MS neurons of the control and at 8 h after ischemia.  (B) Grouped data (1T-4T) 
reveal that the amplitude of evoked IPSCs in MS neurons was significantly 
depressed at 8 h after ischemia.   
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Figure 14 The threshold of stimulus intensity for LA neurons is increased after 
ischemia but not associated with the increased amplitudes of evoked IPSCs.  (A) 
Bar graph shows the threshold of stimulus intensities before and after ischemia.  
(B) Scattered plot shows that the absolute values of 3T were not necessarily 
associated with the amplitudes of evoked IPSCs at 3 h and 24 h after ischemia.  
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Figure 15 Presynaptic release of GABA is increased after ischemia.  (A) 
Representative traces of paired-pulse tests at 3T in LA neurons.  The traces are 
averages of 10 consecutive recordings.  (B) Grouped data show that PPR was 
significantly decreased at 3 h and 24 h after ischemia.   
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Figure 16 The frequency of spontaneous IPSCs is increased after ischemia.  (A) 
Representative traces of spontaneous IPSCs from the control, 3 h, and 24 h after 
ischemia.  (B1) Cumulative distributions of inter-event intervals from the same 
neurons shown in A.  The curve for cumulative probability of inter-event intervals 
showed a leftward shift at 3h and 24 h after ischemia (K-S test, P<0.05).  (B2) 
Cumulative distributions of current amplitudes from the same neurons shown in 
A.  The curve for cumulative probability of current amplitudes showed no change 
after ischemia.  (C1) Bar graph shows that the frequency of spontaneous IPSCs 
was significantly increased after ischemia.  (C2) Bar graph shows that there was 
no significant change in the amplitude of spontaneous IPSCs. 
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Figure 17 The mean amplitude of miniature IPSCs is decreased at 24 h after 
ischemia.  (A) Representative traces of miniature IPSCs from the control, 3 h, 
and 24 h after ischemia.  (B) Cumulative distributions of inter-event intervals from 
the same neurons shown in A.  The curve for cumulative probability of inter-event 
intervals showed no change.  (B2) Cumulative distributions of current amplitudes 
from the same neurons shown in A.  The curve for cumulative probability of 
current amplitudes showed a leftward shift at 24 h after ischemia (K-S test, 
P<0.05).  (C1) Bar graph shows that there was no significant change in the 
frequency of miniature IPSCs.  (C2) Bar graph shows that the amplitude of 
98 
 
miniature IPSCs at 24 h after ischemia was significantly decreased compared to 
the control and 3 h after ischemia.   
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Figure 18 Postsynaptic responses to GABA are depressed at 24 h after 
ischemia.  (A) Representative traces showing LA neuron’s response to 
exogenous GABA application (300 μM) in the control and after ischemia.  (B) 
Grouped data show that the currents induced by exogenous GABA application at 
24 h after ischemia were greatly reduced compared to the control and 3 h after 
ischemia. 
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Figure 19 Muscimol enhances inhibitory synaptic transmission in LA neurons 
after ischemia.  Representative traces of evoked IPSCs and PPR before and 
after muscimol application in the control neurons (A1) and neurons at 24 h after 
ischemia (A2).  (B) Grouped data show that muscimol increased evoked IPSCs 
and decreased PPR in LA neurons after ischemia.  Muscimol did not significantly 
change evoked IPSCs and PPR in the control LA neurons.  All columns were 
normalized to the pre-muscimol application value and are thus called relative 
value (dashed lines). 
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Figure 20 Muscimol decreases presynaptic GABA release in the control LA 
neurons.  (A) Representative traces of spontaneous IPSCs before and after 
muscimol application in the control LA neurons.  (B) Cumulative distributions of 
inter-event intervals and current amplitudes showed a rightward shift after 
muscimol application from the same neuron shown in A (K-S test, P<0.05).  (C) 
Cumulative distributions of current amplitudes showed a rightward shift after 
muscimol application from the same neuron shown in A (K-S test, P<0.05).  (D) 
Grouped data show that the frequency of spontaneous IPSCs was decreased 
while the amplitude of spontaneous IPSCs was increased in the control LA 
neurons after muscimol application.  All columns were normalized to the pre-
muscimol application value (dashed lines).   
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Figure 21 Muscimol increases presynaptic GABA release in LA neurons after 
ischemia. (A) Representative traces of spontaneous IPSCs before and after 
muscimol application after ischemia.  (B) Cumulative distributions of inter-event 
intervals showed a leftward shift after muscimol application (K-S test, P<0.05) 
before and after muscimol application from the same neuron shown in A.  (C) 
Cumulative distributions of current amplitudes showed no change after muscimol 
application from the same neuron shown in A.  (D) Grouped data show that the 
frequency of spontaneous IPSCs was increased and the amplitude of 
spontaneous IPSCs didn’t change in LA neurons after ischemia upon muscimol 
application.  All columns were normalized to the pre-muscimol application value 
(dashed lines).  
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Figure 22 Muscimol’s effect on inhibitory synaptic transmission after ischemia is 
dependent on extracellular calcium.  (A) Representative traces of spontaneous 
IPSCs in the aCSF, Ca2+-free aCSF, after muscimol application (in the Ca2+-free 
aCSF) and washout in the same LA neuron after ischemia.  (B) Bar graph shows 
that the frequency and amplitude of spontaneous IPSCs were greatly reduced in 
the Ca2+-free aCSF.  (C) Cumulative distributions for inter-event intervals from 
the same neuron in A before and after muscimol application in the Ca2+-free 
aCSF.  (D) Cumulative distributions for current amplitudes from the same neuron 
in A before and after muscimol application in the Ca2+-free aCSF.   
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Figure 23 Muscimol’s effect on inhibitory synaptic transmission after ischemia is 
dependent on the voltage-gated sodium channels.  (A) Representative traces of 
spontaneous IPSCs, miniature IPSCs, miniature IPSCs after muscimol 
application and washout in the same LA neuron after ischemia.  (B) Cumulative 
distributions for inter-event intervals of miniature IPSCs from the same neuron in 
A before and after muscimol application.  (C) Cumulative distributions for current 
amplitudes of miniature IPSCs from the same neuron in A before and after 
muscimol application.  (D) Grouped data show that muscimol did not change the 
frequency and amplitude of spontaneous IPSCs in the Ca2+-free aCSF.  All 
columns were normalized to the pre-muscimol application value (dashed lines).  
(E) Grouped data show that muscimol did not change the frequency and 
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amplitude of miniature IPSCs.  All columns were normalized to the pre-muscimol 
application value (dashed lines). 
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Figure 24 A cartoon shows the presynaptic GABAA receptors’ role in the 
modulation of inhibitory synaptic transmission in control and after ischemia.  In 
the control condition, intracellular chloride concentration is low and the reversal 
potential for chloride is more negative than the resting membrane potential.  
Following the activation of presynaptic GABAA receptors, there will be a chloride 
influx and membrane hyperpolarization.  After ischemia, intracellular chloride 
concentration is increased and the reversal potential for chloride is more positive 
than the resting membrane potential.  Following the activation of presynaptic 
GABAA receptors, there will be a chloride efflux and membrane depolarization, 
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which will activate voltage-gated sodium (VGSC) and calcium channels (VGCC).  
Thus, presynaptic transmitter release is increased and a bigger postsynaptic 
response occurs. 
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Figure 25 The immunoreactivity of GAD65 is increased in the striatum after 
transient cerebral ischemia.  (A) Representative images of GAD65 
immunostaining from the dorsolateral striata of control, 1 day, and 3 days after 
ischemia.   Images were taken under 100×.  Scale bar, 100 μm.  (B) The bar 
graph shows a significant increase in the optical density of GAD65 
immunoreactivity after ischemia.  
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Figure 26 The immunoreactivity of GAD65 is increased in the striatum after 
transient cerebral ischemia.  (A) Representative images of GAD65 (green) after 
immunofluorescence staining from the dorsolateral striata of control, 1 day, and 3 
days after ischemia.  Images were taken under 400×.  Scale bar, 10 μm.  (B) The 
bar graph shows a significant increase in the number of GAD65-positive puncta 
after ischemia.  (C) The bar graph shows a significant increase in the optical 
density of the GAD65-positive puncta at 3 days after ischemia. 
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Figure 27 The increase in the immunostaining of GAD65 is not due to the 
ischemic injury.   (A)  Representative images of vGLUT2 immunostaining from 
the striata of control, 1 day, and 3 days after ischemia.  Images were taken under 
100×.  Scale bar, 100 μm.  (B)  Bar graph shows that there was no increase in 
the optical density of vGLUT2 immunoreactivity after ischemia.   
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Figure 28 The increase in the immunostaining of GAD65 is not due to the 
ischemic injury.  Representative images of GAD67 immunostaining from the 
dentate gyrus of hippocampus show a decrease of GAD67 immunoreactivity at 3 
days after ischemia compared to that of the control.  Images were taken under 
400×.  Scale bar, 40 μm.   
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Figure 29 GAD65 expression is increased after ischemia.  (A) Representative 
blots from three independent experiments.  (B) Quantification analysis of the 
relative density of GAD65 in control and after ischemia.  Data are represented as 
mean±SEM. 
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Figure 30 Muscimol application increases the number of survived cells (cells with 
normal morphology) in the striatum after ischemia.  HE staining was performed 
on striatal slices (10 μm) after paraffin embedding.  Rats were subjected to either 
transient cerebral ischemia alone or ischemia plus muscimol intraperitoneal 
injections 30 min before the ischemic insults.  Images were taken from 
dorsolateral and dorsomedial striatum under 200×.  Scale bar, 30 μm. 
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Figure 31 Bar graph shows the number of survived cells in the striatum 
(dorsolateral + dorsomedial) was increased in the muscimol treatment group.  
The number of survived cells in the dorsolateral striatum did not show significant 
increase while in dorsomedial striatum there was a significant increase in the 
muscimol treatment group.  
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